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Abstract
The studies described were undertaken to determine the 
immunegenicity of single cell protein obtained from Candida lipolytica 
grown on n-alkanes (CLP) and to assess its ability to induce 
hypersensitivity tissue damage in the lung and gastrointestinal 
tract.
Induction of humoral immunity was examined in the guinea pig, 
rabbit and mouse. Separated yeast components (whole cells, cell 
contents and cell walls) were used to identify the antigen concerned. 
Production of agglutinating and precipitating antibody was detected 
using prepared CLP antigens. The amount of antigen released during 
in vitro digestion was assessed. In addition, human sera were 
examined for antibody to CLP antigens, CLP induced a weak humoral 
response. The major antigenic material was found in the cell wall 
portion of the yeast, only small amounts of which were exposed 
during the vitro digestion. Certain CLP antigens were recognised 
by agglutinating antibody in human serum.
Induction of cell mediated immunity in guinea pigs was assessed 
by examining lymphocyte proliferation. Each of the yeast components 
was found to be capable of inducing lymphocyte proliferation.
Ability of CLP to induce and elicit type 1 pulmonary hyper­
sensitivity in guinea pig was compared with that of ovalbumin. 
Production of type 111 pulmonary hypersensitivity was examined in 
guinea pigs possessing agglutinating antibody to CLP antigen, CLP 
failed to produce either type 1 or type 111 hypersensitivity tissue 
damage, however, reaginic antibody was detected in guinea pigs 
treated to induce a type 111 hypersensitivity.
11
Production of gastrointestinal hypersensitivity tissue damage 
was investigated in animals sensitized with CLP prior to oral 
exposure. Ingestion of high levels of CLP by parenterally 
sensitized guinea pigs enhanced the humoral response, which 
included production of reaginic antibody. No tissue damage was 
observed.
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CHAPTER 1
Introduction
"Protein" is one of the world's most vital resources for which, 
like many other basic materials, demand has overtaken production. 
Consequently, new sources of protein are continually undergoing 
evaluation. One such product is single cell protein (SCP) which has 
become the accepted term to describe protein derived from unicellular 
organisms either algae, bacteria, yeasts or mycelial fungi.
The concept of using microorganisms as a protein source rather than 
a food additive or processing step is not original. The Aztecs of 
Mexico and the peoples of Lake Chad included the algae spirulina in 
their diet (Delpeuch and Joseph, 1973). Spirulina was used by the 
lake people as a protein supplement, because it was not a food of 
choice it was only used as the sole source of dietary protein in 
famine conditions. Production and consumption of SCP on a major scale 
has only been carried out during the I and II World Wars using 
Candida utilis grown on wood sugar substrates (Scrimshaw, 1975).
Interest in developing new protein sources was renewed when it was 
realised that food production could not support the expanding population 
even allowing for increases in agricultural efficiency. Advantages to 
be gained from developing a new protein source independent of 
agricultural resources are enormous. SCP production would not compete 
for valuable agricultural land, be limited to a growing season nor be 
influenced by climatic changes.
The system chosen would ideally utilise a variety of substrates 
preferably industrial wastes with a negative economic value. In
Finland the PELIKO process has been developed based on spent sulphite 
liquors from the pulp and paper industry. Since it can also utilize 
wastes from the sugar and potato industries, it is not totally 
dependent upon one source of substrate (Romantschuk, 1975).
Manufacture of SCP in underdeveloped areas would require training a 
workforce to run the plant rather than, as with other projects, the 
re-education of whole communities. If SCP became an accepted new 
food it would also reduce a country’s reliance on imported cereals 
and so stimulate the economy.
The projected use for SCP was to replace proteins used in animal 
feeds releasing them for human consumption. Direct feeding to man was 
also contemplated especially for manned space flights using a system 
which both maintained an oxygen atmosphere and provided a food 
resource (Lachance, I968). However, due to a failure to select a 
suitable organism and the difficulties of combining microbiological 
requirements and space technology, SGP was not used in space.
In the early seventies social and economic developments high­
lighted the need to bring experimental SGP processes into fullscale 
production.
Increasing affluence and purchasing power of the industrial 
nations produced a growth in demand for meat products, leaving less 
grain available for export. Plans to increase cereal production 
had encouraged countries like India, Pakistan and Indonesia to grow 
new high-yielding cereals in preference to the traditional legume 
(Brown, I968). These varieties were not resistant to the natural 
pests which over several growing seasons rapidly multiplied, taking 
their toll upon the harvest (Kidwai, 1979).
To obtain high yields from the new strains fertilizers and good
irrigation were necessary, both of which are expensive investments for 
these countries. The overall result was a decrease in legume 
production without any increase in cereal production. In 1972 the 
combination of overfishing and coastal pollution with a shift in the 
Humbolt current off the shores of Peru and Chile substantially 
decreased the anchovy catches, which are the main sources of fish 
meal for pig and poultry feeds. All these factors placed additional 
pressures on the remaining protein resources.
The protein advisory group (PAG) was set up in 1955 to assess the 
safety and nutrition of unconventional food proteins. In 19&9 a 
committee was appointed to examine SGP's in greater detail. From 
this agency came reports and recommendations, the most pertinent 
of which was one on preclinical testing of SGP (PAG Guideline No. 6 
1972); which outlined development of a SGP and the range of tests 
to evaluate its safety.
One of the first problems is the selection of a suitable 
non-pathogenic organism whose toxic factors (endotoxins and exotoxins) 
if any can be removed or reduced to acceptable levels during 
processing. Personnel employed at the SGP plant could come into 
contact with viable SGP organisms which may have pathogenic properties 
not previously recognised. Differentiation between pathogenic and 
non-pathogenic members of a species can be difficult especially when 
dealing with Gandida species, some of which exist naturally as 
commensals, but which develop into infections in immunologically 
suppressed or stressed individuals. Holzschu ^  (1979)
investigated yeast pathogenicity by assessing their invasive properties 
in normal and stressed mice. Yeast cultures were injected intra­
venously and after several days yeast cells were recovered from various
4tissues. G. tropicalis and G. albicans both opportunistic 
pathogens in man, when injected into the mice produced systemic 
candidiasis,colonies of which were found in kidney, brain and heart 
tissues. From other yeasts like G. utilis, G. maltosa and £. 
pseudotropicalis some cells were found in the tissues, but no cells 
were found of G. lipolytica, Torpulopsis sp,, T. pinnus and H. 
polymorpha. Using intracranial injections of G, tropicalis, G. utilis 
and G. maltosa, only G. tropicalis produced colonies in the brain.
This type of test where viable organisms are used appears to 
distinguish successfully those organisms pathogenic to man. The 
presence of toxic components in SGP organisms should not pose a problem 
of acceptance of the new protein source. Many conventional foods
contain harmful substances the art of removing them having evolved
over centuries. Legumes contain agglutinins and haemolysins; 
manioc, cyanide and soya beans an antitrypsin factor.
When considering the use of SGP directly for human consumption
effects of nucleic acid intake are important. Conventional foods such
as liver and cod’s roe contain 2.2 and 5.7 per cent nucleic acid
(Miller, 1968) whereas the nucleic acid content of algae, yeast and
bacteria is high - between 8 and 25 per cent depending on culture
conditions, which is mostly RNA (Sinskey and Tannenbaum, 1975)•
bases
The nucleic acid: guanine and adenine are metabolised to uric 
A
acid. This does not pose a problem to animals fed SGP because they 
possess the enzyme uricase which breaks uric acid down to the water 
soluble allantoin. Studies on the effect of protein and uric acid 
intake in,man by Galloway (1974) showed urinary uric acid increased 
in proportion to intake of purine-free protein. Addition of purines 
to the diet elevated serum uric acid level as well as urinary uric
acid level. Uric acid has a low solubility at physiological pH, a 
rise in serum uric acid may result in crystallization of urate in 
the tissues producing a gouty arthritis. High levels of urinary 
uric acid may produce renal calculi, Galloway (1974) also 
observed that nucleic acids present in the algae Ghlorella 
sorokiniana and yeast Torpulus utilis produced a rise in serum uric 
acid in man confirming that the high levels of RNA in SGP constitute 
a hazard.
The risk, however, of increased uric acid levels with consumption 
of SGP can be removed with reduction of RNA content of the product. 
There are several methods of achieving this available to manufacturers 
such as: heat shock, exogenous and endogenous RNA-ase cell disruption 
and base catalysed hydrolysis with potassium or sodium hydroxide.
Each method has its drawbacks of either cost, time or effect on 
nutritive value of the final product.
Another factor to consider is the choice of substrate that must 
be free of elements like lead, arsenic and mercury which accumulate 
in food chains. The use of animal wastes as substrates may produce 
SGP contaminated with bacteria pathogenic to man. With the use of 
hydrocarbon substrates the question arises of accumulation of 
carcinogenic materials from the substrate either concentrated in 
the cultures organism or from incomplete removal of the substrate.
Hydrocarbon substrates are not pure, gas oil distillates can 
contain polycyclic aromatics. Solvent extraction would be required 
to remove these materials after fermentation. Polycyclic hydrocarbons 
have been shown to induce mammary tumours in rats after a single 
treatment (Huggins et a^., 1961) and long chain hydrocarbons to 
increase their carcinogenic potential (Bingham, I969). However,
Guaitani et (197?) have shown that administration of n-alkanes 
whether even or odd numbered did not affect the carcinogenicity 
directly or increase the potency of the known carcinogens di-methyl- 
benzanthracene and 3-methylcholanthrene using similar tumourogenic 
doses to those used by Huggins et aj, (I96I),
n-Alkane substrates are separated from gas oil distillates by a
molecular sieving process and are 98.5 per cent pure,
14Popovi6 (I970) examined the absorption of G octadecane (G18) 
in rats given a single dose of 50 mg and found labelled GO^ being 
expired after 30 minutes. The major portion of label was found in 
the liver. More recent studies carried out by Bizzi et aT, (1979%) 
using chromatographic techniques, analysed the n-alkane upon which 
Gandida maltosa was grown to produce liquipron. This n-alkane 
consisted of 13 per cent tetradecane (G14), 34 per cent pentadecane 
(GI5), 30 per cent hexadecane (GI6), 22 per cent heptadecane (GI7) 
and 1 per cent octadecane (G18), It was also shown not to contain 
branched or unsaturated paraffins or detectable levels of carcinogenic 
materials. When fed to rats G14, GI5 and GI6 residues were retained 
in the adipose tissue, A single oral dose of 6 mg of hexadecane 
produced peak levels of GI6 in the plasma and began to accumulate 
in the adipose tissue after 3 hours reaching a peak after 24 hours. 
Larger doses of n-alkanes did not increase the amount absorbed.
The absorption and retention of n-alkanes varies with species, 
chickens absorbing the least. Rats fed diets containing eggs from 
SGP-reared chickens (Yoshida, 1979) did not contain levels of n-alkane 
above those found in normal diets, n-Alkanes themselves do not pose a 
toxicological hazard in SGP.
Organisms cultured on hydrocarbons contain a number of fatty
acids not found in such quantities in nature. Toprina produced from 
the yeast Gandida lipolytica grown on n-alkanes contains about lO 
per cent by weight of fatty acids, up to 50 per cent of this is 
composed of heptadecanoic acid (GI7) having the same chain length 
as the principal alkane in the substrate (heptadecane GI7)
(Bernadini, et al., 1975). This product also has a high level of 
phospholipid and low amount of triglyceride.
"Pruteen" a bacterial SGP produced by growing Methylophilus 
methylotrophus on methanol contains high concentrations of palmitic 
and palmitoleic acid but also low levels of a rare cyclopropane 
fatty acid (Steel et a3^ ., 1979). The presence of large amounts of 
odd : fatty acids in the diet poses the problem of whether this 
would affect digestibility, the alteration of foetal and neonatal 
development and also the consequences of their incorporation in 
structural lipids of membranes and brain. These problems have been 
examined by Tomassi and Serlupi-Grescenzi (1979) using Toprina, and 
Bizzi et al. (1979&) using Liquipron. The! odd Î fatty acid content
of these SGP's did not affect litter size, weight or weaning of rats
even though odd |fatty acids cross the placenta and are secreted 
in milk. The levels of odd fatty acids in adipose tissue increase
with the concentration of SGP in the diet, a peak is reached which
will remain constant even with prolonged periods of exposure. Upon 
removal of SGP from the diet, odd  ^fatty acid levels in adipose 
tissue returned to control levels within one month indicating that 
the! odd jfatty acids are metabolised.
Designing of toxicity tests for new protein sources produces 
problems not usually encountered because the item tested comprises 
the major part of diet. Gare is required to assure that effects
observed are directly due to protein being tested and not an oversight
in diet design. Animal feeds are formulated from a variety of plant
and animal proteins to ensure nutritional balance. Yeast and
bacterial SGP contain high levels of methionine but are low in
threonine, lysine and tryptophan and are therefore ideal for mixing
with cereals. Trace elements are also important their absence in
SGP reflects deficiencies in the substrate, Yoshida (197?) examined
thirteen types of bacterial and yeast SGP's produced in Japan
utilising both methanol and n-alkane substrates. The yeast proteins,
one of which was C. lipolytica, were particularly low in selenium and
were used as the sole source of dietary protein in chicks. These 
exudative
developed diathesis, symptoms of selenium and vitamin E deficiency,
A
When selenium was incorporated into the diet or substrate, recovery was 
observed,
ShacKLady (1976) fed n-alkanes or gas oil grown SGP to chicks, 
selenium deficiency occurred which had not been observed in previous 
trials using broiler chickens. When the deficiency was corrected the 
performance of gas oil grown SGP improvedp but that of n-alkane SGP 
remained low, A difference in texture was responsible for this; gas 
oil SGP had a granular texture whilst u-alkane SGP was a fine powder 
which settled out from the other diet components and was not. consumed, 
producing a dietary imbalance. Performance of n-alkane SGP was 
improved by altering its particle size. These trials emphasise how 
important correct formulation and presentation of a new protein diet 
is when assessing the nutritive value and safety of the product. The 
nutritional value of the new protein source depends on the amount of 
available protein not total protein present, Shacklady (I969) compared 
the performance of pigs and poultry fed on yeast SGP and found SGP
to compare favourably with normal diets with a protein replacement 
of up to 80 per cent, but this was not a prolonged exposure. Feeding 
SGP to cattle would not produce a problem because they have the 
digestive system to cope with cell wall material,
Toxicological examination of all novel proteins would have to 
satisfy recommendations laid down in PAG guidelines. One SGP which 
has been extensively tested, Toprina, is derived from the organism 
Gandida lipolytica which can be grown on gas oil or n-alkanes,
A one year feeding study which incorporated up to 30 per cent 
gas oil SGP in diet fed to rats (De Groot et ^ , , I969) produced a 
transient effect on leucocyte counts, but did not produce any 
pathology or alterations in kidney and liver function. The corres­
ponding study on n-alkane SGP (De Groot et , 1970) also showed no 
adverse effects. Two year carcinogenicity and mutagenicity studies 
were combined, the gas oil SGP (De Groot et , 1971) a,nd the 
n-alkane produced SGP (De Groot et , 1975) failed to show any 
carcinogenic activity or effects on reproduction and support of young, 
but serum enzymes were elevated in the n-alkane SGP fed rats,
Shacklady (1976) reported on additional experiments carried out 
on Toprina. A mutagenicity and teratology study in which the male 
rats received 60 per cent SGP and the female rats 30 per cent SGP in 
the diet produced no adverse effects. The ir vitro Ames test also 
failed to detect a mutagenic effect. Studies on SGP toxicity to 
macrophages were also negative.
Toxicity tests ^  vivo and ir vitro have suggested that the SGP's 
tested were not unsuitable for human consumption, however5 feeding 
programmes in humans presented a new set of difficulties not 
previously encountered. Hydrogenomonas eutropa a hydrogen fixing
10
bacteria developed as a SGP for use in space systems was tested in 
rats (Shapira and Mandel, I968) and replaced up to ?0 per cent 
protein in the diet for 26 days. At high dietary levels food intake 
and growth rates were reduced and water intake, urine and faeces 
production increased. When H. eutropa SGP was fed to human volunteers 
they experienced abdominal discomfort followed by weakness and pain 
in the extremities (Waslein et a2,, I969), Using the same feeding 
regime, they fed H, eutropa and Aerobacter aerogenes SGP's grown 
under different culture conditions to human volunteers. A, aerogenes 
SGP produced symptoms similar to those previously observed with the 
H, eutropa SGP and one subject developed a skin rash. The effects 
produced by H, eutropa SGP were reduced.
Scrimshaw (1972) fed 12 volunteers with 90 g per day of Torula 
yeast grown on sulphite liquor for 11 weeks. After 5 weeks of feeding 
one subject experienced gastrointestinal symptoms and high uric acid 
levels were measured in both urine and serum. Between the 3rd and 
8th week of feeding eight of the subjects developed desquamation of 
the palms and soles of the feet. The feeding programme continued and 
the lesions disappeared within 24 hours of their appearance. Yeast 
industrially used in food produced symptoms of nausea, vomitting and 
diarrhoea (NYD) and an erythematous rash, Gulture on a glucose medium 
removed the cutaneous response in most individuals (Scrimshaw, 1972), 
Using a yeast grown on ethanol and a bacteria grown on ethanol, 
both of which had been extensively tested in animals, 20 g per day 
also produced a NVD syndrome. Intake was discontinued and upon a 
second exposure a stronger reaction was observed, Ihe subjects' 
symptoms did not recur when fed an acid washed SGP sample,
G. utilis and G. lipolytica SGP's which had been thoroughly
11
tested in animals were treated with alkali to reduce their RNA content 
and the risk of producing high uric acid levels. These samples 
were then fed to human volunteers (Scrimshaw, 1979). The 
characteristic NVD syndrome developed within 3-4 days with the 
G. lipolytica SGP which Scrimshaw suggested could be a delayed 
hypersensitivity response. Again washing of the SGP with acid 
removed the symptoms, this was thought to be due to the removal of 
HgS from the SGP, but many conventional foods have higher levels of 
HgS present and do not produce this effect, Gandida utilis biomass 
which had been treated with alkali at 70°G to reduce RNA levels 
produced a cutaneous response between the 3^^ to 11th days of feeding 
in the form of erythematous and p^itic eruptions. Subsequent 
feeding with the non-RNA reduced yeast and samples treated with alkali 
at 130°G did not produce this effect.
Scrimshaw went on to examine lymphocyte proliferation to 
extracts of the RNA reduced yeast in the G,utilis fed volunteers.
This was increased in sensitized and exposed individuals although 
the responses obtained were much less than those obtained from 
stimulation with the mitogen PHA, He considered this to indicate 
an allergic response.
The data on human consumption of SGP show that the RNA content
is unacceptable because of the risk of increased uric acid levels
, content ,
in serum and urine. Reduction of nucleic acid in the SGP's produces
A
a toxic agent in both bacterial and yeast SGP regardless of substrate 
used. The importance of maintaining a good quality control system 
is also emphasised as a slight alteration in processing can produce 
unwanted side-effects. It is also important to ensure that other 
organisms pathogenic to man do not contaminate the fermentation.
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However, the fact that SGP may have immunogenic properties is 
somewhat disquieting when considering the prospect of its incor­
poration into basic foodstuffs.
Immunological testing of SGP and other materials for consumption 
using animal models has not in general been investigated other 
than atopic sensitivity to chemicals, A proportion of the population 
exhibitshypersensitivity responses to the food they eat, well-known 
examples are shell fish, strawberries and milk products. Some 
individuals also show intolerance to even basic food constituents 
such as gluten from wheat flour. An article in the Lancet (FIin and 
Gohen, 1978) reported case histories of six patients who presented 
symptoms which did not respond to conventional treatments over a 
period of years. Eventually, in each instance the cause of illness 
was identified as intolerance to tea, coffee, alcohol, chocolate or 
potatoes - foods considered normal dietary constituents. When these 
items were removed from the diet the symptoms resolved. Once the 
offending substance has been identified, it can be avoided, however, 
extensive inclusion of a new protein source in foods will make 
identification and avoidance extremely difficult.
Recently, Hemmings (1978) found that in the rat half the ingested 
protein was not broken down to amino acids and small polypeptides 
but absorbed as large molecular weight fragments which retain their 
antigenicity, Ihese he detected in the brain and postulated that 
they were responsible for migraine and unexplained mental disease.
Apart from the risk to sensitive individuals of SGP in the diet, 
there is the possibility of sensitizing normal individuals to a new 
antigen. In addition there exists the problem of inhalation during 
manufacture or use. There are many documented examples of allergy
13
produced by occupational exposure to organic dusts; e.g. Byssinosis 
(Roach and Schilling, i960) and bakers* asthma (Hendrich et al.,
1976); alpha amylase and papain (Flindt, 1979) and soya bean (Bush 
and Gohen, 1977) have also been implicated in occupational allergies. 
The hazard also exists for those living and working in the vicinity 
of a factory handling allergenic material, Kathren et ad, (1958) 
reported asthma allergy to castor bean,occurring in employees in a 
pipe factory downwind of a fertilizer plant handling castor bean 
pomace. The same problem on a larger scale occurred with the castor 
bean oil mills in Marseilles (Panzani, 1957). Not only did castor 
bean dust produce allergic disease in mill workers and subsidiary 
industries workers, but also produced allergic rhinitis in asthmatic 
persons living near the factories. Amounts of dust in the atmos­
phere were aggravated by the Mistral wind and reduced during wet 
weather. It is important that the stringent safety precautions taken 
during the manufacture of SGP are maintained when it is handled by 
other industries. Secondary exposure to a potent allergen by 
inhalation or ingestion is also possible, as illustrated when castor 
bean pomace was used as the protein source in fish food (Layton,
1977). The antigenic element of castor bean pomace was retained in 
the flesh of the cat-fish, an extract of which produced positive 
passive cutaneous anaphylaxis responses when tested using sera from 
castor allergic patients. Withdrawal of castor bean pomace from 
the diet for one week prior to harvesting removed the antigenic 
material from the flesh.
It is now being realised that immunology has an important role 
to play in evaluation of compounds for inclusion in animal and 
human diets, Amos (1979) suggested ways in which animal models
14
could be developed to determine immunogenicity of a SGP and assure 
product quality, these were based on the genetic control of the 
immune system. Selective breeding of responsive and non-responsive 
animals to SGP antigens could detect alterations in antigen profile, 
however, although selection of responsive strains has applications 
throughout the food and drug industries, their development will take 
a considerable period of time.
The aim of the following experimental programme was to examine 
the antigenicity of the SGP produced from G, lipolytica grown on 
n-alkane (CLP) and its ability to induce hypersensitivity responses 
in lung and gastrointestinal tract. Investigations were carried out 
with a view to establishing animal models to determine the immuno­
potency of novel protein sources.
15
CHAPTER 2
Assessment of the immunopotency of Gandida lipolytica protein
from its ability to induce humoral antibody production 
and lymphocyte proliferation
2.1 INTRODUCTION
The organism G. lipolytica does not express invasive pathogenic 
properties (Holzschu, 1979)» but when CLP is presented to the immune 
system it may be a potent antigen stimulating both the humoral and 
cellular immune responses. It is therefore important to be able to 
establish the immunogenic potential of CLP and its significance 
with relation to man.
The nature of Gandida antigens and the humoral response to 
Gandida infections have been extensively examined. Summers et alp 
(1964) identified the main antigenic material of the Gandida species 
as the mannans found in the cell wall and demonstrated antigenic 
cross-reactivity between members of the group. This was subsequently 
confirmed by Murray and Buckley (I966) who found at least eight 
antigenic domains were present in various combinations within the 
Gandida species.
Thirty per cent of healthy human volunteers have been shown to 
possess agglutinating antibody to G, albicans (Winner, 1955). 
Stallybrass (1964) proposed that agglutinating antibodies are to be 
found in cases of superficial candidiasis, whereas precipitating 
antibodies are present in systemic infections.
In the present study agglutinating antibody was detected using
16
the passive haemagglutination test of Boyden (1951) in which soluble 
antigen was attached to red blood cells. Unfortunately, the whole 
yeast cell preparation formed agglomerates in suspension, thus 
precluding their use as an indicator cell.
Precipitating antibodies were detected by the double immuno­
diffusion test of Ouchterlony (1948), Both these methods only 
require small amounts of serum which is advantageous when using 
small laboratory animals in experimental models.
Cell mediated immunity towards Gandida pathogens can be 
assessed using vitro lymphocyte proliferation assays to detect 
specific sensitivity to these organisms, Ihis technique has been 
employed by Baker e^ a^ , (i9?6) to demonstrate the involvement of 
actinomyces and certain gram-negative anaerobes in peridental disease. 
Similarly Scrimshaw (1979) examined lymphocytes from individuals who 
had developed cutaneous lesions after ingestion of G, utilis SGP 
and found increased cell proliferation following vitro culture 
with extracts of the SGP,
It is therefore important to determine if GLP can initiate a 
cell mediated immune response. In this study the method used to 
examine lymphocyte proliferation following antigen stimulation was 
based on the microculture technique described by Oppenheim and 
Schechter (1976) which measures increase in DNA synthesis by 
incorporation of tritiated thymidine.
In the following study the immune response to CLP was examined 
in three types of animal to investigate species specificity. Separated 
components of the yeast were used to enable identification of the 
antigenic portion of the yeast.
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2,2 MATERIALS
2.2.1 Animals
Female Dimkin Hartley guinea pigs were obtained from Porcellus 
Breeding Ltd at a weight of 150-200 g and were fed Oxoid SGI Diet, 
Female mice, Theilliers Original Swiss Strain, were obtained 
from A, Tuck and Son Ltd and fed Spratts Laboratory Animal diet. 
Female half lop rabbits were obtained from Ranch Rabbits Ltd 
and fed Ranch Rabbit diet.
All animals were kept under standard animal house conditions, 
given food and water ^  libitum and were acclimatised for one week 
before treatment began.
2.2.2 Adjuvant
Freunds complete adjuvant (FCA) obtained from Difco Ltd was 
emulsified with an equal volume of antigen solution using an 
Elvehjem Potter homogeniser with a ground glass pestle. When 
injected the adjuvant ensures the antigen remains at the injection 
site and enhances the immune response to the antigen,
2.2.3 Tissue Culture Media
All tissue culture reagents were obtained from Wellcome 
Reagents Ltd,
Hanks Balanced Salt Solution (HBSS) x  10 strength (TO 5^ ) 
was diluted to single strength with sterile distilled water and to 
loo ml diluted HBSS, 0,8 ml of sodium bicarbonate solution (TG 2?) 
was added to give a pH of 7,2
Eagles Minimal Essential Medium (MEM) single strength (TG 29)
-1 -1containing 200 units ml" penicillin, 100 pg ml" streptomycin and
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sodium bicarbonate 1,1 g 1 was heparinized using 10 lU ml" heparin
—1(Paynes and Byrne 10,000,lU ml" ) to prevent clumping. This
heparinised Eagles medium (HEM) was used for lymphocyte culture.
Mycoplasma free foetal calf serum (ECS) was tested for mitogenic
activity in the test system used. The serum was heat inactivated for
45 minutes at to remove complement before use and diluted to
20 per cent with HEM.
2.2.4 Radio Isotopes
Tritiated thymidine (Radiochemicals,Amersham TKR 6I) was used 
to measure DNA synthesis. It was diluted in HEM to give a specific 
activity of 20 pCi ml ^,
2.2.5 Reagents
Analar grade chemicals used were obtained from British Drug 
House Ltd.
Enzyme powders pancrease and pepsin were obtained from 
Sigma Ltd,
Phosphate Buffered Saline (PBS) Dulbecco A buffer tablets 
(Oxoid Ltd) were dissolved in double distilled water.
Bovine serum albumin (BSA) obtained from Sigma Ltd was dissolved 
in PBS to give a solution of 0.1 mg ml" (Diluent).
Tannic acid (Judex Laboratory Chemicals Ltd) was made into 
a 0.05 mg ml  ^solution in PBS,
Sterile saline for diluting antigen for injection was obtained 
from Baxter Ltd,
Noble Agar was obtained from Difco Ltd.
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2.2.6 Mitogen
Hiytohaemagglutinin (HA16) solutions (Wellcome Ltd) were made up 
freshly each day in HEM to give final concentrations of 0,5» 5 a,nd 
50 pg ml“^ ,
2.2.7 Candida lipolytica Rcotein (CLP) Samples
Candida lipolytica grown on n-alkanes was supplied hy the 
manufacturer in several forms;
2.2.7.1 The spray dried product: This consisted of a mixture of
whole cells and cell debris,
2.2.7.2 Wet preparations of the yeast: These samples had been taken 
before spray drying and were supplied as the whole cells, cell wall 
portion and remaining cell contents fraction,
2.2.7.3 Enzyme digestions of CLP spray dried product : These had
been carried out to expose the antigenic sites. Thirty ml of a 10
-1per cent suspension of CLP had been incubated with 1 mg ml" of either 
amylase, lipase chymotrypsin, pancrease, pepsin or trypsin for 3 hours 
at 37°G, The incubations had been carried out at pH 7.5 except for 
the pepsin incubation which was done at pH 2,
Supernatant samples had been taken at three stages during 
digestion. Ten ml aliquots were taken, centrifuged at 3500 rpm for 
15 minutes and supernatant collected after (a) 3 hours incubation of 
CLP with enzyme. Sample S; (b) after incubation was passed through a 
french press to disrupt the yeast cell. Sample FP, and (c) after 0,5 g 
of sodium dodecyl sulphate had been added to the remaining FP incubate 
for 20 minutes, sample SDS, Control incubations at zero time, pH 2 
and pH 7.5 for each supernatant sample were also provided, making a 
total of 27 samples (Appendix l),
2.2.7.4 Mannan extracts: These had been prepared from CLP cell walls
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and separated on a DEAE sepharose column using an increasing potassium 
chloride gradient. The samples provided were mannan and four 
fractions designated TMPA, TMPB, TMPB I and TMPB III, In addition 
mannan extracts were also provided from RNA-reduced CLP samples 
which had produced an NVD syndrome during human feeding trials.
These were;
i. Sample 721, which had been RNA reduced at pH 10 for 3O-60 minutes, 
washed three times in water and then an isopropyl alcohol (iPA);
this produced severe NVD,
ii. Sample 722, RNA reduced at pH 9 for 3O-60 minutes washed three
times in water,' then IPA; this produced severe NVD,
iii. Sample 724, RNA reduced at pH 9 for 3O-60 minutes acid washed 
at pH 2, washed three times in water then IPA; this produced slight 
NVD,
iv. Sample 725» RNA reduced using RNA-ase, washed three times in
water; this produced slight to moderate NVD,
V, Sample 7271 no information on method of RNA content reduction or 
severity of NVD syndrome,
2,3 METHODS
2,3.1 Double Immunodiffusion Technique
Noble agar was dissolved in 0,3 M potassium phosphate buffer to 
give a 1.5 per cent solution. This was poured on to glass plates,
2 mm holes punched out and either sera or antigen placed in selected 
wells. The plates were kept at 4°G for 6 days for precipitation 
lines to develop then washed in PBS at 4°G for 24 hours to remove 
unprecipitated protein. They were then dried and stained with
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—1thiazine red (Raymond A, Lamb) 1 mg ml" in 1 per cent acetic acid 
for 6o minutes and destained using 1 per cent acetic acid in 70 per cent 
alcohol.
2.3.2 Passive Haemagglutination Test
Sheep red blood cells (SRBC) in Alsevers solution (Oxoid Ltd)
were washed three times by suspension in PBS and centrifugation at
800 g for 15 minutes, supernatant removed and the SRBC diluted to
4 per cent SRBC in PBS, One volume of 4 per cent SRBC suspension was
—1mixed with 1 volume of tannic acid solution (0.05 mg ml" PBS) and
incubated at 37°C for 20 minutes. The SRBC were washed twice in PBS
(350 g for 15 minutes). Half the tanned SRBC were made up to a 4
—1per cent suspension in diluent (BSA 0,1 mg ml" PBS), The packed, 
tanned SRBC remaining were incubated with 1 ml of 1 mg ml" mannan 
extract TMPB III at room temperature for 1 hour,then washed once in 
PBS and diluted to 4 per cent SRBC in diluent. Sera were heat 
inactivated at 56°G for 45 minutes, titrated in diluent at log 2 
intervals using 25 pi volumes in "U" well microtitre plates 
(Sterilin Ltd M24A). The plates were kept at 4°G overnight and 
agglutination assessed. An example of a typical response obtained 
i:'S shown in Figure 2,1a and b using sera obtained from animals treated 
as described in section 2.5.2, Agglutination titre is the reciprocal 
of the maximum serum dilution giving a positive agglutination, thus 
agglutination obtained at a dilution of 1:8 is quoted as titre of 8,
A titre of below 8 was considered negative,
2.3.3 Lymphocyte Proliferation System
Guinea pigs were exsanguinated by cardiac puncture and the blood
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Figure 2.1 Passive haemagglutination test. Patterns of agglutination 
obtained using sera from guinea pigs treated with 1 mg CLP
a) sera titrated against tanned SRBC.
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b) Sera titrated against tanned SRBC labelled with mannan TMPB III
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placed in tubes containing EDTA (Teclab) to prevent Clotting.
Cervical and mesenteric lymph nodes were removed aseptically and 
placed in a sterile petri dish containing HBSS. Separation of 
lymphocytes from blood and lymph node tissues was carried out under 
sterile conditions using a laminar flow cabinet (Bassaire Ltd.,
Model 3HH).
2.3.3.1 Blood lymphocyte separations
Blood was diluted with an equal volume of HBSS and 4 mis of 
this mixture layered on to 3 mis of Ficoll-paque (Pharmacia Ltd) 
in a sterile 10 ml tube (Sterilin Ltd, 142AS). When centrifuged 
at 800 g for 45 minutes the blood separated into its component parts, 
the lymphocytes being located in a pale band at the HBSS-Eicoll 
interface. This was collected and the cells washed three times in 
HBSS by centrifugation at 350 g for 15 minutes, and resuspended in 
HEM. Lymphocyte number was counted using a new improved Neubauer 
haemocytometer and the concentration adjusted to give 4.0 x 10^  
lymphocytes ml ^.
2.3.3.2 Lymph node lymphocyte separation
Fat and connective tissue around the lymph nodes were removed and 
the nodes placed in fresh HBSS, They were then teased out to 
release lymphocytes into the medium. The cell suspension was then 
washed, counted and adjusted to 4 x 10^ lymphocytes ml”^ .
2.3.3.3 Preparation of CLP antigens
CLP wet preparations (2.2.7.2) and dry powder (2.2.7.1) were not 
sterile and contained some gram-negative bacilli. To reduce the 
possibility of bacterial contamination of the culture system the
yeast samples were washed (7OO g for 15 minutes) twice in sterile saline, 
twice in HBSS and twice in HEM. They were then resuspended in HEM and
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diluted to give concentrations of 20, 2.0, 0.2 and 0.02 mg ml" .
The use of heat sterilization would have altered the antigenic 
specificity of the yeast preparations,
2.3.3.4 Lymphocyte proliferation assay
Lymphocyte culture was carried out in flat bottomed microtitre 
plates with lids (Sterilin M29AR TL). The cells and media were 
dispensed using a Hamilton syringe calibrated to deliver 50 pi.
To each well was added one volume of HES, one volume of 20 per cent 
ECS, one volume of lymphocyte suspension and one volume of antigen 
solution, producing a culture system with 5 per cent FGS and 
2 X 10"^ lymphocytes per well. Replicates of six wells were set 
up for each antigen concentration. The lymphocytes were cultured 
at 37 0^ in a 5 per cent CO^ atmosphere saturated with water vapour 
for 44 hours. One volume of tritiated thymidine (20 pCi ml" ) was 
added for the final 4 hours of culture.
The cultures were harvested using an automatic cell harvester 
MASH II (Dynatech Ltd) on to glass fibre papers using distilled 
water to disrupt the cells and washed through with 400 ml of distilled 
water to remove any unbound radioactivity. When dry the glass fibre 
discs were separated and placed in vials containing liquid scintillant 
NE 233 (Nuclear Enterprises Ltd) and the radioactivity measured on a 
Packard 2650 scintillation counter.
2.3.4 Digestion of CLP using Artificial Digestive Juices 
Artificial gastric and small intestine juices were made according
to the method of Longland ^  (1977).
Thirty ml of 10 per cent spray dried CLP suspension in PBS were 
incubated with 1 ml of gastric juice for 3 hours at 37°G in a shaking
25
water bath. Half the incubate was brought to pH 7.5 with 0.1 N sodium 
hydroxide and incubated for a further 3 hours with 1 ml of small 
intestine juice. Samples of gastric and small intestine juice 
digestions were treated ultrasonically with an MSE I50 watt 
Ultrasonic disintegrator for three times three seconds at low power 
to disrupt the yeast. Samples were cooled on ice between dis­
integrations. Supernatant samples were taken by centrifuging at 1000 g 
for 15 minutes after gastric digestion, small intestine digestion 
and ultrasonic treatments. To increase antigen concentration the 
7 ml samples were reduced to 2 ml using a Diaflq^ filter with a 
UM 10 membrane (Amicon Ltd).
2.4 EXPERIMENTAL
2.4.1 Induction of Antibody Production Against CLP Net Preparations 
Each of the wet CLP preparations (2.2.7.2 whole cells, cell walls 
and cell contents) were used to sensitize guinea pigs, rabbits and 
mice. The amount of antigenic material received and route of 
administration varied with species. Guinea pigs received either 
10, 1 or 0,1 mg of "antigen" combined with FCA by subcutaneous 
injection. Rabbits received either 40, 4.0 or 0.4 mg of antigen 
combined with FCA by intramuscular injection and mice either 15,
1.5 or 0.15 mg of antigen by intraperitoneal injection. The details 
of the sensitization procedures are shown in Table 2.1. Five animals 
were treated at each dose level in the case of guinea pig and mouse 
and one for the rabbit species. Serum samples were prepared from 
blood collected before treatment and at 2-weekly intervals after 
sensitization. Guinea pigs and rabbits were bled from the ear vein
26
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and mice from the tail vein. Serum from blood obtained at 0, 2,
10 and 18 weeks after sensitization was examined for the presence 
of antibody by double immunodiffusion (Section 2.3.1) using the 
mannan extracts at a concentration of 1 mg ml PBS. Serum samples 
obtained at 18 weeks were tested using the undiluted enzyme 
digestions of CLP (2.2.7.3). Passive haemagglutination tests were 
carried out on the serum samples obtained 2 weeks after sensitization 
from guinea pig and mouse and after 0, 2,10 and 18 weeks after 
sensitization from rabbit. The antigen used to label the SRBC was 
the mannan extract TMPB III, Lysis of SRBC occurred when labelling 
with the CLP enzyme digestions (2,2,7.3) was attempted,
2,4.2 Profile of the Humoral Response to CLP and the Relationship
between Agglutinating and Precipitating Antibody Formation
To obtain information on the appearance of precipitating
antibodies in relationship to the development of agglutinating
antibody, eighteen guinea pigs were sensitized with 1 mg of spray
dried CLP preparation. This was combined with FCA using the same
schedule as in Section 2.4,1 above and two control animals were
treated with FCA and saline. Sensitized animals were divided into
three groups of five with three spare animals. Serum samples were
obtained by cardiac puncture from Group A at 1, 4, 7» 10, 13, 18 and
30 weeks; Group B at 2, 5, 8, 11, 14 and 30 weeks and Group C at
cardiac puncture was 
3, 6, 9, 12, 16 and 30 weeks. Where^ unsuccessful," serum samples
were obtained from a spare animal. Control serum samples were
obtained every 2 weeks, for details see Table 2,7. Sera were
examined for agglutinating antibody against mannan by passive
haemagglutination (Section 2.3.2) using the mannan extract TMPB III
28
and for precipitating antibodies to the mannan extracts (2.2,7.4) 
and enzyme digestions (2.2.7.3).
2.4.3 Determination of Cross-reactivity between the Various Mannan 
Extracts
To discover if there was any cross-reactivity between mannan 
TMPB III and the other mannan extracts an inhibition study was carried 
out. The SRBC were labelled with mannan TMPB III (Section 2,3.2) but 
10 pi of 1 mg ml of the mannan extracts was added to the titrated 
sera and incubated at room temperature for 30 minutes prior to the 
addition of the labelled cells. Sera examined were from animals 
which had been sensitized and fed CLP (see Chapter 4). In addition 
a sample of mannan TMPB III was heated at 65°C for 6 hours, because 
Ho et al, (1979) had demonstrated that this treatment destroyed one 
of the antigenic components of Candida albicans, this heat treated 
material was assessed as an inhibitor, SRBC were also labelled with 
mannan preparations not producing inhibition to check that they were 
not antigenically different.
2.4.4 Examination of Human Sera for the Presence of an Agglutinating 
Antibody to Mannan
Serum samples from 18 human volunteers were tested for 
agglutinating antibody to CLP mannan TMPB III. To reduce non-specific 
agglutination Human 0 Red Blood cells were used as the indicator 
cell in the passive haemagglutination test. Sera were also examined 
for precipitating antibody to the enzyme digests (2,2,7.3) a.nd mannan 
extracts (2.2,7.4),
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2.4.5 Production of CLP Antigen by Incubation with Artificial 
Digestive Juices
To reproduce the events in the gastrointestinal tract which may 
reveal the antigenic areas of CLP, digestions of CLP were carried 
out using artificial digestive juices (Section 2.3.4), The antigen 
solutions were tested against sera which had produced precipitin 
responses in other experiments (see Chapter 4), To determine if the
antigen was heat labile it was heated at 65°C for 6 hours and
retested against the sera. These antigen preparations also proved 
unsuitable for labelling SRBC,
2.4.6 Lymphocyte Proliferation in Guinea Pigs
Using the guinea pigs sensitized with the wet. yeast preparations 
(Section 2.4ol) one animal was selected from each dose level and 
examined for lymphocyte proliferation as described in Section 2.3.3= 
Blood and lymph node lymphocytes from each animal were challenged 
in vitro with the relevant CLP preparationso They were also challenged
with PHA to establish that the culture system was working and to
detect altered reactivity to mitogen. To determine if CLP had a 
mitogenic activity lymphocytes from an unsensitized guinea pig were 
challenged with CLP (2.2,7.1),
The final concentrations of antigen in culture were 1, 0,1, 0,01
—1 —1 
and 0.001 pg ml" for CLP antigens and 12,5, 1.25 a,nd 0.125 pg ml"
for PHA,
2.4o7 Statistical Analysis of Lymphocyte Proliferation Results
Data from lymphocyte proliferation cultures are not normally 
distributed (Oppenheim and Schecter, 1976) therefore to examine the 
data from Section 2.4.5 the distribution free method of Kruskal and
30
Wallis (1952) was employed (Brady, I968; Langly, 1973). This is a 
non-parametric method of analysis used to compare three or more 
unmatched random samples of measurements.
2.5 results
2,5.1 Induction of Antibody Production against CLP Wet Yeast 
Preparations
Injection of CLP wet yeast preparations induced agglutinating 
antibody production in all three species examined, Guinea pigs 
produced this type of antibody in response to CLP whole cells, cell 
contents and cell wall preparations (Table 2,3:), only animals 
treated with the lowest level 0,1 mg of cell contents failed to 
produce agglutinating antibody. Mice were less responsive than the 
guinea pigs and all the mice treated with the cell contents preparation 
gave a negative response (Table 2,2), Untreated rabbits sometimes 
possess agglutinating antibody to Candida and this was seen in 
presensitization serum samples in which some animals gave a titre 
of 8 to CLP mannan (Table 2,4). Treatment with CLP wet yeast 
preparations boosted the agglutinating antibody titre, of which 
the cell wall preparation appeared most effective at inducing 
agglutinating antibody production which remained constant over the 
16 week period.
The induction of precipitating antibody to mannan was poor.
Table 2,5 shows the details of each animal which produced precipitating 
antibody against CLP mannan extracts. No precipitating antibodies to 
CLP mannan extracts were detected in sera from guinea pig or mouse 
except for one mouse receiving 15 mg of whole cells which reacted with
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extracts TMPA, TMPB, TMPB I and TMPB III at 2 and 10 weeks after 
sensitization. Rabbits given whole cells also produced a negative 
response, whilst rabbits treated with cell contents produced the 
faintest of precipitin lines. Rabbits treated with cell walls, however, 
produced well demarked precipitin lines. The response was first 
detected at 10 weeks in animals receiving 0.4 mg of antigen and at 
18 weeks in animals given 4 mg of antigen. There were two patterns 
of response, rabbits treated with cell contents reacted with low RNA 
yeast extract 721, whilst those treated with cell walls reacted with 
mannan extracts TMPA, TMPB, TMPB III.
Detection of precipitating antibody using the enzyme digestion of 
CLP was more successful but only the cell wall treated animals 
reacted with these antigens. Most of the antigenic activity was 
found in the SDS sample of the digestions and some in the FP sample 
(Table 2,6). Mouse produced a good response at all dose levels. All 
animals that responded reacted with CLP treated with the non-protease 
enzymes amylase, pancrease and lipase and several animals reacted with 
all the CLP digestions. Guinea pigs given 10 mg of antigen responded 
best, most animals reacted with CLP digested with protease enzyme chymo- 
trypsin and the non-protease enzymes pancrease and lipase. The rabbit 
given 40 mg of cell walls whose serum did not react with mannan 
extracts did so with the FP samples of pancrease and lipase digestions.
2.5.2 Profile of the Humoral Response to CLP and the Relationship 
between Agglutinating and Precipitating Antibody Formation
The passive haemagglutination titres obtained from each animal 
sensitized with CLP (2.2.7.1) over a 30 week period are shown in 
Table 2.7. Following the response of each animal it can be seen that
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Table 2.7 Passive haemagglutination titres obtained from guinea 
pi#s injected with 1 mR of CLP from 0-30 weeks
Bleed week No. 1 4
Haemagglutinatic 
7 10
>n titre
13 18 30
Animal No.
CLP 1 mg A1 0 32 128 64 256 32 32
" " ” A2 0 64 128 256 256 64 32
" " " A3 0 16 32 64 - 32 16
" " ” aA 0 32 16 64 1028 32 64
" " " A5 0 - 512 128 1028 64 64
Saline D4/D5 0 - 8 — 0 - 0
Bleed week No, 2 5 8 11 14 30
CLP 1 mg B1 2 64 512 256 1028 32
" " " B2 16 16 16 • 32 32 16
M I I  I I 32 - 256 256 128 16
I I  I I  I I  PA 32 32 32 64 16
1,  I I  I I  3 ^ 2 128 32 64 D
Saline D4/D5 - 2 0 - -
Bleed week No. 3 6 9 12 16 30
CLP 1 mg Cl 128 256 128 32 32
I I  I I  I I  Q2 32 32 64 64 D
I I  I I  I I 4 32 32 64 128 32
I I  I I  I I  q A 64 256 256 128 512 64
I I  I I  .1 16 256 128 128 2056 32
Saline D4/D5 0 - 0 - - -
Bleed week No. 3 4 5 13 14 16 30
CLP 1 mg D1 2 16
I I  I I  I I  32 32 2056 64 64
I I I 3^ 16 64 16
- No sample 
D = Animal Died
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Figure 2.2 Profi le of agglutinin and precipit in  
production in guinea pigs t rea ted  
with 1 mg C L P  from 0 - 3 0  weeks
LU
CO
4-1 1 2
c
CO
CD
2
CNi
1
1 0
1
o
X
0 8
V
4-»
P
>
"D
O
6
SI
4-1
c
< 4
D )
C
4-»
(U
c
2
4 -;
3
O )
D )
< 0
O )
c 4 -
4-* >
0 “ O
4 J o
’ q .
Ü
0
4-»
c
<
Û .
e n z y m e  d igests  
c o n t r o l  d iges ts  
m a n n a n
-//- 302 4 6 8 10 12 14 16 18
W E E K S
S t r e n g t h  of p rec ip i t in  l i n e s -  IB Strong.  
13 M o d e r a t e .  E l  W e a k .  12 Jus t  v is i b l e ,  
t  one square equals one animal.
40
in some animals sensitization had been more successful and they were 
more reactive towards CLP antigen.
There were intra-individual differences in the appearance of 
agglutinating antibody and the development of maximum response. When 
plotted these results showed a sharp rise in agglutinating antibody 
titre up to 7 weeks, the titre continued to rise until 14 weeks after 
which there was a gradual decline in titres obtained. At 30 weeks 
the level of agglutinating antibody had settled at titres between 
16 and 64 (Fig. 2.2). Appearance of precipitating antibody was 
transient, precipitin lines obtained against lipase, pancrease, 
chymotrypsin and amylase digests were extremely weak between weeks 4 
and 7. One animal produced good precipitin lines at 14 weeks to all 
the enzyme digests and the mannan extracts TMPA, TMPB, TMPB I and 
TMPB III. It was also the only animal to produce a precipitin 
response against the control digestions FP and SDS at pH 7 sind pH 2. 
The precipitin lines against the mannan extracts especially TMPB III 
were particularly well demarked and are shown in Figure 2.3.
2.5.3 Determination of Cross-reactivity between the Various Mannan 
Extracts
Substantial reductions in haemagglutination titres were obtained 
when 10 pi of mannan extracts TMPA, TMPB, TMPB I and TMPB III were 
added to- the assay system before the TMPB III labelled SRBC. Mannan, 
721, 722, 723, 725 and 727 failed to reduce the haemagglutination 
titre (Table 2.8). Sera tested against SRBC labelled with the low 
RNA yeast mannans did not produce titres above 8. This indicates 
that they did not contain other separate antigenic areas not detected 
using TMPB III labelled cells (Table 2.9)
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Figure 2,3 Double immunodiffusion assay. Precipitin lines
obtained against mannan extracts using sera 
from guinea pigs treated with 1 mg CLP
72 1 M A N N A N
„ T M P B  I I I  T M P A
T M P B I  T M P B
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Table 2.8 Inhibition of passive haema^^lutination response to 
TMPB III with mannan TMPA, TMPB, TMPB I, TMPB III 
721, 722, 723. 725, 727 and heat treated TPMB III
Labelled SRBG Inhibitor Haemagglutination titres 
14 15 16 104*
Unlabelled Diluent 0 0 0 0
TMPB III Diluent 128 32 64 128
I I Mannan 128 32 64 128
I I TMPA 2 0 0 2
I I TMPB 8 0 4 2
I I TMPB I 4 0 0 8
I I TMPB III 2 0 0 2
I I 721 128 32 32 128
I I 722 128 32 32 128
I I 724 128 32 32 128
I I 725 128 32 32 128
I I 727 128 32 32 128
Unlabelled TMPB III HT 128 32 64 128
TMPB III II 128 32 64 128
*Sera from animais in Chapter 4 
HT = Heat treated 65°G for 6 hr.
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Table 2,9 Agglutinating antibody response against mannans not 
cross reacting with TMPB III
Labelled SRBC Haemagglutination titres 
14 15 , 16 104*
721 0 0 2 2
722 2 0 4 2
724 0 0 4 4
725 2 2 4 4
727 0 2 2 4
*Sera from animals in Chapter 4
Heat treating mannan extract TMPB III removed its ability to 
inhibit the agglutinating antibody to TMPB III SRBC indicating that 
its antigenic site was heat labile.
2.5.4 Examination of Human Sera for the Presence of an 
Agglutinating Antibody to Mannan 
When human sera were examined for antibody against CLP antigens 
it was found that 58 per cent of volunteers possessed agglutinating 
antibody at a titre of above 16, but did not have precipitating 
antibody to either the mannan extracts or enzyme digestions of CLP 
(Table 2,10). These results are in agreement with the findings of 
Winner (1955) and Stallybrass (1964) but also shows cross-reactivity 
between CLP mannans and Candida pathogen mannans.
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Table 2,10 Passive haemagglutination titres obtained from 
human sera against mannan TMPB III labelled 
human G RBG
Labelled RBC
Total
Haemagglutination titre 
0 2 4 8 16 32 64 above I6
Male volunteers
Unlabelled ■ 5 1 2  1 1
TMPB III 
labelled 1 3 1 20^ n
Female volunteers 
Unlabelled 13 0 4 7 1 1
-38%
TMPB III 
labelled 3 4 5 1 46%.
2,5.5 Production of CLP Antigen by Incubation with Artificial 
Digestive Juices 
To determine if antigenic sites had been revealed through 
digestion of CLP with artificial gastric and pancreatic juices, 
the incubations were tested against sera from animals known to 
possess precipitating antibodies. No antigen was detected after 
initial digestion with gastric or small intestine juices even after 
mechanical disruption, however, upon concentrating with the diaflow 
system, sera 101 and I6 reacted with the sonicated small intestine 
incubation (Table 2,11), When the incubations were heated at 65°C 
for 6 hours antigenic activity could no longer be detected, 
indicating that this antigen was heat labile.
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Table 2.11 Precipitating antibody against antigen produced by 
serial digestion of CLP with artificial digestive 
.juices
Serum*
No.
DIGESTION
Gastric Small Intestine
Control Digest Disrupted Control Digest Disrupted
Unconc,
14
16
101
104
105
Cone.
14
16
101
104
105
t
HI cone 
14 
16 
101
104
105
* Serum No. 14 possessed antibody against mannan.
Serum Nos, l6,' 101 and 105 possessed antibody to the enzyme 
digestions of CLP and serum No. 104 to both.
HI = Heat inactivated at 65°G for 6 hours.
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2.5.6 Lymphocyte Proliferation in Guinea Pigs
Lymphocyte proliferation results are shown in Tables 2.12 and 
2.13 for blood and lymph node lymphocytes. Examination of these 
results shows that variation between replicates was large. The 
occurrence of exceptionally high levels of proliferation was about 
1 in 20, precluding their omission from any analysis. An overall 
analysis of blood and lymph node results was carried out using the 
Kruskal-Wallis test (see Section 2.4.?). The rank totals obtained 
from the analysis of the effect of sensitizing and challenging 
antigen and the significances of differences between the individual 
samples are shown in Table 2,14. The overall levels of significance 
were P< 0.001 providing strong evidence that there is an interaction 
between challenging and sensitizing antigens, i.e. the level of 
proliferation obtained from each of the challenging concentrations 
was dependent on the amount of antigen used for sensitization.
The presence of interaction between the antigen sensitizing 
and challenging concentrations make it difficult to determine their 
effects on the culture system. However, if this is temporarily 
neglected and the main effect of challenging antigen concentrations 
on blood and lymph node cultures examined, a highly significant 
result of P< 0,001 is found which rejects the null hypothesis of no 
effect. From the rank totals it can be seen that 1 mg of challenge 
antigen for blood cultures and both 1 mg and 0,1 mg challenge antigen 
for lymph node cultures produced significant levels of proliferation 
compared with the control cultures. This is borne out in the 
original data except for the unsensitized animal given CLP (2.2,7.1).
On examining the main effect of sensitizing agent there is 
also very strong evidence (P < O.OOl) of an effect. The differences
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Table 2.14 Rank totals obtained from analysis of in vitro
lymphocyte proliferation in guinea pig using the 
Kruskal-Wallis test
overall significance -y2 d.f.
Blood 89.17*** 28
Lymph nodes 134.31*** 36
Significance of Rank sums
d.f.
Effect of challenging antigen (mg)
1 0.1 0.01 0.001 0
Blood
20.02** 4 157* 98 94 95 21
Lymph nodes
20.21 4 153* 123* 87 85 21
Effect of sensitizing antigen (mg)
Whole cells cell contents cell walls 0
10 1 0,1 10 1 0.1 10 1 0.1 0
Blood
27.64** 7 232 58 ND 156 53 205 102 17 194
232** 52 205*
232* 58 205*
Lymph nodes
48.38*** 9 307 1 68 41 289 145 203 286 239 115 22
307** 289** 286** 239* 22
307** 41 289** 286** 239*
307* 115
Rank sums marked with an asterisk are significantly different from
the sum underlined: *P < 0.05
**P < 0.01 
***P < 0.001
N.D. Not determined because of insufficient cells
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between levels of proliferation obtained with each of the CLP wet 
preparations was not easily discernable. Rank totals for blood 
cultures indicate that 10 mg of antigen was most efficient for 
sensitization, especially so with whole cells and cell walls. The 
1 mg of cell walls appears more active than its whole cell and cell 
contents counterparts. In lymph node cultures all three sensitizing 
agents were successful at inducing lymphocyte proliferation. 
Statistical analysis of the responses to PHA were not carried out 
because a complete set of results was not available, therefore the 
results were expressed as percentage control proliferation and are 
shown in Table 2.15. All animals responded to PHA mostly at the 
1.25 Rg challenge level. Only one animal appeared more responsive 
but upon referring to Table 2.13 it can be seen that high levels of 
proliferation were obtained with low control values. CLP does not 
appear to have impaired the ability of these animals to respond to 
mitogen stimulus.
2.6 DISCUSSION
Experiments examining the immunopotency of CLP have shown that 
it is capable of stimulating both the humoral and cellular immune 
response. Use of separated components of yeast for sensitization 
have identified that antigenic material is present in the cell wall. 
The range of precipitating antibody responses obtained against the 
antigen preparations reflect variations in individual immune 
responsiveness and the numerous possibilities for antigenic material 
present within a product derived from whole organisms.
Yeast cell walls are composed of glucan, chitin, mannan, lipid
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and protein. It can only be speculated where breakdown of the cell
walls occurred during the enzyme digestions to expose antigenic
conformations, because specificity and purity of the enzymes used
were not stated. In all three species examined, all animals which
responded produced a maximum response to the CLP lipase digestion
followed by pancrease and amylase digestions. Cell wall lipids are
i they are
thought to have a structural function for when removed the yeast 
becomes flattened, not retaining its oblate spheroid shape (Rogers 
and Perkins, 1968). The success of the lipase digestion at exposing 
antigenic sites suggests that either part of the lipid portion is 
antigenic or more probably that sufficient lipid was removed to 
allow access to other antigenic cell wall materials, Pancrease may 
have acted upon esterase bonds between the mannan and protein, 
whilst amylase may act on the N-acetyl glucosamine pi-4 linkages of 
chitin, both producing a substantial breakdown of cell wall structure. 
The comparatively weaker action of the protease enzymes on antigen 
exposure could be due to resistance of Candida yeasts to proteolytic 
activity as Nickerson (I963) found when examining G. albicans. 
Antigenic activity found in the FP and SDS treated portions of the 
digestions were probably the result of mechanical disruption and 
destruction of the tertiary structure of protein increasing exposure 
of antigenic sites. Under less severe conditions of breakdown of the 
yeast using digestive juices and mechanical disruption a concentration 
step was necessary to produce sufficient antigen for the immuno­
diffusion test indicating that the yield of antigenic material through 
digestion is low. The fact that only two out of the five animals 
possessing antibody against the enzyme digests reacted with the 
digestive juice antigens shows how use of SDS increased the number of
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available reactive sites.
Digestion of CLP using artificial digestive juices indicated that 
the breakdown of the yeast took place in the small intestine. This 
observation was consistent with the findings of Hibino et (1974), 
who using the electron microscope showed that in pigs, poultry and 
fish, fed n-alkane grown yeast, digestion of the yeast took place 
in all gastrointestinal organs except the stomach. They also observed 
an elevation of the enzymes glucanase and chitinase to facilitate yeast 
breakdown.
Numbers of animals producing precipitating antibody were low 
compared with those producing agglutinating antibody responses. Only 
a small quantity of antigen therefore was sufficient to induce 
the agglutinin response, especially with whole cell and cell contents 
preparations, which is in keeping with the concept that agglutinating 
antibody is produced in superficial Candida infections and 
precipitating antibody in systemic infections (Stallybrass, 1964),
The responses from mice showed that adjuvant was not essential 
to induce a humoral response against CLP, Production of agglutinating 
antibody was minimal and in mice treated with cell contents absent. 
Perhaps a clearer picture as to which CLP wet preparation contained the 
antigenic material would have been obtained if FCA had not been 
employed, this applies more especially to the lymphocyte proliferation 
responses.
Despite the presence of agglutinating antibody to mannan not 
all animals went on to develop a precipitin response. The transient 
appearance of precipitin in animals treated with dry CLP (2,2,7.1) 
detected against the enzyme digests occurred at 4-10 weeks during the 
first peak of agglutinin production. The one animal producing a good
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response did so during the second, higher peak of agglutinin activity. 
It is difficult to determine if the level of agglutinating antibody 
is important for precipitin formation, as guinea pigs given CLP cell 
walls were producing precipitating antibody at 18 weeks when their 
agglutinin titres would have been at a residual low level. The 
lack of precipitin response to dry CLP (2,2,7,1) could be due to a 
combination of factors, insufficient cell wall material given and 
partial destruction of antigenic sites during processing.
Production of precipitating antibody against mannan extracts 
was low except in rabbits which can already possess agglutinating 
antibody. Human sera examined for agglutinins against CLP mannan 
gave positive responses indicating that C. lipolytica mannans can 
cross-react with those of human pathogens. If man responds in a 
similar manner to rabbit, a good precipitin response against mannan 
would be expected, but heat treatment destroyed the antigenicity of 
TMPB III and the product of the digestive juice incubations, therefore 
commercial preparations similarly treated may not pose an 
immunological hazard.
Inhibition of the agglutinin response with mannan extracts 
showed that only mannan which passed through the DEAE sepharose 
column was antigenically active, and that the untreated yeast crude 
mannan extract was inactive. There is the possibility that the 
antigenic material of the low RNA yeast may have been removed during 
alkali treatment to reduce RNA content, as protein, mannan, and 
polyglucose are leached out of the cell wall. It was however ingestion 
of these low RNA yeasts that originally produced the NVD syndrome 
in man.
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Each of the wet preparations, whole cells, cell contents and 
cell walls was capable of inducing lymphocyte proliferation in 
guinea pig when administered with EGA. It was impossible because of 
interaction between the factors examined to draw firm conclusions on 
efficiency of dose levels of sensitizing antigen and which preparation 
was most immunogenic.
The measurement of cellular immune response by lymphocyte 
proliferation is a sensitive technique used clinically to determine 
specific immune recognition. Thus this technique can be used to 
assess manifestations of cellular immunity long after traces of ' 
circulating antibody have disappeared. The reason for conflicting 
evidence as to the immunogenicity of the wet yeast preparations 
between the antibody and lymphocyte proliferation studies could be 
either that the cellular immune response is more sensitive, responding 
to small amounts of cell wall material in preparations of whole cell 
and cell contents, or that another antigenic material is present.
Whole cells and cell contents preparations will contain quantities 
of RNA which could be immunogenic and an RNA antigen was not used
to detect antibody in the serum analysis. Whole yeast cells were used
in the enzyme digestions thus some RNA material would have been 
present unless it had been sufficiently altered during incubation,
A clearer picture of which preparation contained antigenic material 
may have been produced if more animals had been examined and if EGA 
had been omitted from the sensitization regime.
The results from this first set of experiments have shown that
GLP was capable of inducing a weak humoral response in the three 
species of animal examined, seen either as agglutinin or precipitin 
production. The response obtained against separated wet preparations
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indicated that the antigenic material resided in the cell wall 
portion of the yeast. CLP was also capable of inducing lymphocyte 
sensitization in guinea pigs whichever portion of the yeast was 
administered. The organism C. lipolytica was shown to possess 
antigens in common with those of other members of the Candida group. 
Examination'of the GLP antigens, mannan and the product of digestion 
have revealed them to be heat labile.
57
Appendix I, Samples provided from the digestion of CLP with 
various enzymes (2.2.7.3)
Enzyme Supernatant Samples Incubation
pH
S FP SDS
Amylase + + + 7.5
Ghymotrypsin + + + I
Lipase + + + I
Pancrease + + + I
Trypsin + + + I
No enzyme + + + I
Pepsin + + + 2.0
No enzyme + + +
S = supernatant taken after initial digestion
FP = supernatant taken after French press 
treatment
SDS = supernatant taken after treatment with sodium 
dodecyl sulphate
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CHAPTER 3
Assessment of the ability of Candida lipolytica protein (CLP) 
to induce and elicit hypersensitivity tissue damage
in the lung
3.1 INTRODUCTION
It was established in Chapter 2 that CLP had weak antigenic 
properties. CLP was examined to determine if, as a proteinaceous 
dust, it presented an immunological hazard through inhalation. The 
study concentrated upon allergic lung disease produced by type I 
and type III hypersensitivities as classified by Coombs and Cell
(1963).
c
The type I hypersensitivity, or anaphyla^ic response is 
characterised by the presence of reaginic antibodies. These are also 
referred to as homocytotrop.icantibodies because the Fc portion 
binds to receptor sites present on the surface of mast cells from the 
same species, thus leaving the antibody combining sites available 
to react with specific antigen. When exposed to antigen the 
sensitized mast cells degranulate releasing an array of pharmacological 
mediators including histamine, serotonin, slow reacting substances of 
anaphylaxis (SRS-A) and eosinophil chemotatic factor (ECF). These 
lead to constriction of the bronchiolar smooth muscle, an increase 
in vascular permeability and an influx of eosinophils into the area. 
This type of response is termed an immediate hypersensitivity and 
occurs within 20 minutes of antigen inhalation producing acute 
respiratory embarrassment which can be fatal.
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A type III hypersensitivity occurs 4-6 hours after antigen 
inhalation, in the presence of antigen specific precipitating IgG 
antibody. Interaction between the antigen and excess antibody 
forms insoluble immune complexes which activate the classical 
pathway of the complement system, producing components such as 
C3a which is an anaphyto toxin and can produce histamine release, 
and G5a which is chemotatic for neutrophils. Complement components 
can also produce platelet aggregation with the subsequent release of 
vasoactive amines and reactive lysis of cells. This results in an 
inflammatory response which in the lung is referred to as an 
extrinsic alveolitis. This disease is often related to occupation, 
habit and hobby; the antigen can be of fungal origin as in 
bagassosis and malt workers lung or of insect or animal origin 
as in bird fanciers and pituitary-snuff takers lung. The best known 
example, however, is farmers' lung which involves activation of the 
alternate complement pathway produced by the inhalation of fungal 
spores from mouldy hay.
The species chosen for this animal model was guinea pig which 
will easily produce quantities of reaginic antibody. Like man, it 
is highly sensitive to histamine and produces reaginic antibody to T 
independent antigens (Tada, 1975). The reaginic class of antibody 
in man is IgE and in guinea pig both IgG and IgE classes have been 
found (Parish, 1970). These can be distinguished because IgE is 
heat labile and can also remain in passively sensitized skin for 
up to 46 days (Perini and Mota, 1973).
The technique adopted for introduction of CLP into the animal 
was that of intratracheal injection used by Parish ^  al. (i960) to 
investigate cot deaths through inhalation of milk proteins and which
6o
has been successfully used to examine inhalation of castor bean
pomace by Anderson et al, (1979). This method is suitable because
the exact amount of antigen placed in the trachea is known and
consequent effects are not complicated by concomitant oral
sensitization. The vehicle, however, in which the antigen is 
ed
suspend'may be responsible for aspects of pathology found, and this 
should be remembered when assessing damage.
In this study reaginic antibody was detected using the ir vivo 
passive cutaneous anaphylaxis test (PGA) of Ovary (1964). The skin 
of a recipient guinea pig is sensitized by passive transfer of 
antibody. After time has elapsed for binding of antibody to the 
mast cell surface, antigen and a protein binding dye are introduced 
intravenously. An increase in vascular permeability is visualised 
by dye extravasation.
In the work described below the immunogenicity of GLP was 
compared with ovalbumin, a potent allergen known to produce anaphylaxis 
in both man and guinea pig.
3.2 MATERIALS
3.2.1 Animals
Female Dunkin Hartley guinea pigs were obtained and maintained as 
previously described in Section 2.2.1,
Guinea pigs which had been sensitized by treatment with 1 mg 
whole cell preparation as described in Section 2,4.1 were also used.
3.2.2 Antigen
Ovalbumin Sigma Grade II was diluted in sterile saline to give
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-1concentrations of 0,1 and 0,01 mg ml ,
3.2.3 Candida lipolytica Protein (CLP) Samples
Candida lipolytica grown on n-alkanes was supplied by the 
manufacturer in several forms.
3.2.3.1 A finely ground CLP sample.
This had been finely ground to reduce the particle size to 5 p. 
CLP enzyme digestions as previously described in Section 2,2,7,3.
CLP mannan extracts as previously described in Section 2.2,7.4.
3.3 METHODS
3.3.1 Intratracheal Injection
The guinea pig was gently restrained, A wire gag was used to 
keep the mouth open so that the nasal speculum could be inserted 
which was then opened to dilate the buccal cavity. The tongue was 
depressed to prevent the swallowing reflex and 0,1 ml of antigen 
suspension was introduced into the trachea using a smooth-ended 
dosing needle (Fig. 3.1). A successful injection was accompanied 
by transient cyanosis,
3.3.2 Passive Cutaneous Anaphylaxis
A normal guinea pig weighing 600-900 g was shaved using electric 
hair clippers. It was then injected intradermally with 0.1 ml of 
saline, serum and serum dilutions of 1:10 and 1:100, from test 
and control animals.
Injection sites were placed along either flanlc and their 
position marked. After a latent period of either 5» 24 or 72 hours,
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Figure 3.1 Intratracheal administration of antigen
\
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Figure 3.2 Demonstration of passive cutaneous anaphylaxis 
technique
4
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the animal was anaesthetised with an intraperitoneal injection of 
0,6 ml/loo g body weight of 25 per cent urethane. The external 
jugular vein was cannulated using pp 50 tubing attached to a three 
way tap (both from Arnold Horwell Ltd), One ml of homologous 
antigen 1 mg ml" saline was slowly introduced into the circulation 
via the jugular vein. This was followed by 0,1 ml/lOO g body weight 
of Evans blue dye 20 mg ml"^  saline (Eastman Kodak Ltd), which was 
washed in with 0,5 ml saline.
Presence of reaginic antibody was assessed by extravasation of 
dye at the injection site within 30-60 minutes as shown in Figure 3.2. 
The area of "blueing" was more easily distinguished if the animal was 
killed and the skin reflected to expose the lesion on the inner 
surface. Diameters of reaction sites were measured using a trans­
parent ruler and the area calculated,
3.3.3 Double Immunodiffusion Technique
This was carried out as previously described in Section 2.3.1.
3.4 EXPERIMENTAL
3.4.1 To Assess the Ability of GLP to Induce and Elicit a Type I 
Pulmonary Hypersensitivity 
Guinea pigs were treated intratracheally with either the ground 
GLP or ovalbumin. The vehicle for the antigens was sterile saline. 
Suspensions of CLP were made to give concentrations of 10, 1, 0,1 and 
0,01 mg ml" , dilutions of ovalbumin were 0,1 and 0,01 mg ml" , 
Intratracheal injections were carried out as in Section 3.3.1 giving 
a dosage of 1, 0,1, 0,01, 0,001 mg for CLP or 0,01 and 0,001 mg
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ovalbumin per intratracheal injection. Each group consisted of 5 
animals. Three control animals received 0.1 ml sterile saline per 
intratracheal injection.
The treatment regime for sensitization and challenge is shown 
in Table 3.1. Animals were "sensitized" with 3 intratracheal 
injections on alternate days. After an interval of at least 10 days 
they were challenged at weekly intervals up to 6 weeks as indicated 
in Table 3.1. Dosage was increased in latter treatments to increase 
the likelihood of a response. Each animal was carefully observed 
after each treatment for signs of anaphylaxis. The responses were 
graded using a system based on the observations of Parish et al.
(i960). These were;
D Death following instantaneous onset of anaphylAic
shock.
+++ Severe respiratory embarrassment denoted by deep
convulsive breathing and repeated coughing.
++ Respiratory embarrassment shown by increased
respiration rate abdominal breathing which may be 
associated with nose rubbing and abdominal grooming,
+ Mild respiratory distress seen as increased respiration
rate and raised neck hair.
No response.
Histology was carried out on those animals which gave the greatest 
response at final challenge. All animals were killed by exsanguination 
by cardiac puncture, the blood was collected and serum samples 
separated. The chest wall was opened, macroscopic observations of
the lung were made and the lungs were removed together with the 
trachea.
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Table 3»1 Type I hypersensitivity sensitization and challenge 
regime
+ Number Intratracheal InjectionsAntigen per
dose group Sensitization Challenge
Saline 
0.01 ml 
CLP 
1.0 mg 
0.1 mg 
0.01 mg 
0.001 mg 
Ovalbumin 
0.01 mg 
0.001 mg
111 I I
1 1 I \f
1111
1 1
M i l
Treatment at week
+ Amount of antigen received per sensitizing intratracheal 
injection
i Challenged with 0.1 x sensitizing dose 
I Challenged with 1 x sensitizing dose 
I Challenged with 10 x sensitizing dose
6?
The lungs were gently inflated with 10 per cent formol saline to 
ensure fixation before being placed in fixative. Tissue samples from 
each lobe were processed, embedded in paraffin wax, 5 h sections cut 
and stained with Ehrlichs haematoxylin and eosin using standard 
histological techniques. Sections were also stained with May-Grunwald 
Giemsa and Lendrum's chromotrope R to aid identification of 
eosinophilic infiltrates which can be found in type I and type III 
hypersensitivities.
Sera were examined for precipitins against either ovalbumin or 
mannan extracts (2.2.7.4) and CLP enzyme digests (2.2.7.3) "by 
immunodiffusion (2.3.1)•
Presence of reaginic antibody was detected by passive cutaneous 
anaphylaxis using homologous antigen. To ascertain whether IgG or 
IgE was involved, sera were heated at 56°G for k hours before 
retesting.
3.4.2 To Assess the Ability of CLP to Induce and Elicit a Type III 
Hypersensitivity Response 
Four guinea pigs weighing 800-850 g sensitized with 1 mg CLP 
whole cells (Section 2.4.1) and which possessed agglutinating antibody 
to mannan were used 8 weeks after sensitization.
The animals received four sensitizing intratracheal injections 
during the first week of treatment and were subsequently challenged 
at weekly intervals for 6 weeks (Table 3.2).
The procedures for monitoring clinical anaphylaxis, post mortem 
examination and serum analyses were identical to those used for type I 
hypersensitivity (Section 3o4.l)c
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Table 3.2 Type III hypersensitivity sensitization and
challenge regime for guinea pigs given 1.0 mg 
whole cells
Antigen
dose
+ Number Intratracheal Injections
group Sensitization
1.0 mg
Treatment at week 1 2 3 4 5 6 7 ;
Amount of antigen per intratracheal injection
3.5 results
3.5.1 Clinical Observations
3.5.1.1 Type I hypersensitivity
Clinical observations obtained after each intratracheal injection 
are given in Tables 3.3& and b. Only one animal given 0.01 mg ovalbumin 
exhibited classical anaphylaxis which occurred on the sixth challenge. 
Within one minute it experienced extreme difficulty exhaling, its 
gait became unsteady, it collapsed in a cyanosed condition and died 
within 4 minutes. Animals given CLP showed signs of respiratory 
distress but did not develop anaphylaxis. Saline treated animals 
showed mild shock after some manipulations. Observations of 
abdominal grooming and nose rubbing were more prominent in the 
ovalbumin-treated groups but were also noted in the CLP-treated 
groups.
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Table 3,3a Clinical observations for guinea pigs given either 
ovalbumin or saline by intratracheal injection to 
induce type I hypersensitivity
Antigen
dose
Animal
number
Challenge at week
3 ^ 5 6 7 8
Ovalbumin 1 - - - - -H- D
0.01 mg 2 + - - ++ ++ ++
3 + - - - ++ +
4 + + ++ 0 0 0
5 + - - -H- -H- -
Ovalbumin 21 + -
0.001 mg 22 + -
23 + -
24 - -
25 - ++
Saline 
0.1 ml
31
32
33
+
-
0 Animal died 
- No response
+ Mild respiratory distress
++ Respiratory distress 
+++ Severe respiratory distress
D Death
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Table 3.3b Clinical observations for guinea pigs given CLP by
intratracheal injection to induce type I 
hypersensitivity
Antigen
dose
Animal
number
3
Challenge
4 5
at
6
week
7 8
6 - + — —
7 - - -H- +
1 mg 8 - + ++ -
9 - + ++ -
10 - + ++ -
11 - -
12 - -
0.1 mg 13 - +++
14 — -
15 - -
16 “ — + - -
17 + ++ ++ -
0.01 mg 18 + + -H- + -
19 ++ + ++ - +
20 — - - ++ +
26 + -
27 + -
O.OOl mg 28 + -
29 + +
30 + -
No response 
+ Mild respiratory distress 
++ Respiratory distress 
+++ Severe respiratory distress 
D Death following anaphylactic shock
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3.5.1.2 Type III hypersensitivity
These animals showed signs of respiratory distress. Animal 6 
experienced a prolonged bout of severe respiratory embarrassment 
(Table 3.4). None of these animals developed anaphylactic shock.
Table 3.4 Clinical observations for guinea pigs treated with 
CLP whole cell preparation then given CLP by intra­
tracheal injection to induce a type III hyper­
sensitivity response
Antigen
dose
Animal
number 2
Challenged at week
3 4 5 6 7
6 - - ++ - - 4-H-
1 mg 7 -H- - - - - +
9 + + - ++ - +
8 - 0 0 0 0 0
0 - Animal died 
- No response 
+ Mild respiratory distress 
++ Respiratory distress 
+++ Severe respiratory distress
D Death following anaphylactic shock
3.5.2 Autopsy and Histological Findings
3.5.2.1 Type I hypersensitivity
Lungs of guinea pigs treated with ovalbumin were pale and remained 
inflated even when the chest wall was cut. Those from animal 1 which
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developed anaphylactic shock completely filled the thoracic cavity.
The other 0,01 and 0,001 mg ovalbumin-treated animals showed only 
partial inflation of some lobes. Animals 1 and 25 also had 
irregular bright red haemorrhagic areas on the lung surface. 
Histological examination revealed a patchy non-budded emphysema and
areas of RBG in the alveolar spaces (Fig, 3.3a and b).
The upper lobes of animals treated with CLP in particular were 
dark red and collapsed, in some cases involving complete lobes.
All animals had areas of alveolar thickening (Fig. 3.4a and b), Areas
of consolidation were present scattered throughout the lungs, 
especially in the upper lobes and the peribronchial lymphoid tissue 
was more prominent in these lobes. Bronchial hyperplasia was noted 
in animal 19 given 0.1 mg CLP. The special stains for demonstration 
of eosinophil infiltrations did not show an increase of these cells 
in treated animals.
3.5.2.2 Type III hypersensitivity
The upper lobes of these animals were also discoloured and 
collapsed with occasional areas of alveolar thickening and 
consolidation. In addition to these lesions were those of peri­
vascular cuffing of mononuclear cells not confined to the perivascular 
space and debris in the alveolar spaces, which consisted of desquamated 
alveolar epithelial cells and alveolar macrophages (Fig. 3.5a and b). 
Also observed was an emphysema in which the majority of alveoli 
remnants were budded, indicating the lesion had been produced before 
the final challenge. The alveoli did not show an acute inflammatory 
response as would be expected in a type III allergic alveolitis.
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Figure 3.3 Guinea pig lung treated with 0.001 mg ovalbumin showing 
a non-budded emphysema and red blood cells in the 
alveolar spaces
L  “ ■
"V
. . ."I r>F'':y . ,p'.^3 >
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'f " <«
%
m
b) High power x 400
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Figure 3.4 Control guinea pig lung showing background changes 
of generalized alveolar thickening
a) Low power x 35
4
b) High power x 400
75
Figure 3.5 Lung from a guinea pig treated with CLP to induce 
type III hypersensitivity showing thickening of 
the alveolar wall with debris in the alveolar spaces
r y - m
a) Low power x 35
; ^  -^ 4£* \  Éà m
f  y .
i
b) High power x 400
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3.5.3 Serum Antibody Analysis
3.5.3.1 Type I hypersensitivity
All animals receiving 0.01 mg ovalbumin demonstrated reaginic 
antibody up to titres of 1 in 100 (Table 3.5). Figure 3.6a and b 
shows the response obtained from animal 3. No animal given 0.001 mg 
ovalbumin had detectable levels of reaginic antibody despite the 
histological evidence of anaphylaxis. Saline and CLP treated groups 
were also negative. None of the animals examined possessed 
precipitating antibodies to ovalbumin or CLP enzyme digests and 
mannan extracts. Heat treatment of the sera did not abolish reaginic 
activity which was still present at ?2 hours after passive transfer, 
but in some cases the reaction area was markedly decreased.
3.5.3.2 Type III hypersensitivity
Reaginic antibody was found in animals 6 and 9 (Table 3.6), but 
no precipitin activity was detected against CLP enzyme digests or 
mannan extracts,
3.6 DISCUSSION
Previous experiments examining induction of type I hyper­
sensitivity have involved intraperitoneal injection of antigen before 
intratracheal challenge. In this study it was intended to induce and 
elicit hypersensitivity responses by the intratracheal route 
stimulating the asthma type conditions where the lung is the main 
portal of entry. The use of guinea pigs possessing an agglutinating 
antibody to mannan to investigate type III hypersensitivity responses 
in the lung was made to encompass the situation in which a section 
of the human population possess agglutinins which recognise CLP mannan,
( (
Table 3•5 Reaginic antibodies found in guinea pigs given either
ovalbumin or saline by intratracheal injection to
induce a type^hypersensitivity 
A
Antigen Animal Area of extravasation of dye mm
2
dose number 5 hr 24 hr 72 hr*
Neat 1/10 1/100 Neat 1/10 1/100 Neat 1/10 1/100
1 133 33 0 491 133 13 95 0 -
Ovalbumin 2 64 0 - 214 7 - - - -
0.01 mg 3 - - - 490 177 50 452 0 -
4 - - - 154 1 - - - -
5 - - - 760 361 113 530 12 -
21 0 0 — 0 0 - - - -
Ovalbumin 22 - - - 0 0 - - - -
0.001 mg 23 - - - 0 0 - - - -
24 - - - 0 0 - - - -
25 0 0 - 0 0 - - - -
31 0 0 0 0 0 0
Saline 
0.1 ml 32 - - - 0 0 0 - - -
33 — — 0 0 0 — — —
*Serum heated at 56 G for 4 hr 
- Estimation not done
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Figure 3.6 Passive cutaneous anaphylactic response obtained 
from guinea pig No. 3 given 0.01 mg ovalbumin
OVALBUMIN OVALBUMIN
SERUM NEAT SERUM 1- 10
a) Areas of extravasation of dye from serum neat and diluted 1:10
SALINE
OVALBUMIN 
SERUM 1 : 100
b) Areas of extravasation of dye from serum diluted 1:100 and saline
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Table 3.6 Reaginic antibody found in guinea pigs treated with
CLP to induce type III hypersensitivity tissue damage
9
Area of extravasation of dye mm'"
Antigen Aniraal  ^ 24 hr
dose number
Neat l/lO l/lOO Neat l/lO l/lOO
6 0 0 0 123 2
Img 7 0 0  0 0 0
9 0 0 - 346 177
- Estimation not done
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In this assay system CLP did not induce clinical anaphylaxis as 
did the positive control ovalbumin. Clinical observations between 
guinea pigs treated with CLP and ovalbumin were similar, even those 
ovalbumin-treated animals with histological signs of anaphylaxis 
showed only moderate respiratory distress indistinguishable from that 
seen in CLP-treated groups. The importance of observations such 
as abdominal grooming and nose rubbing is that they are indicative 
of histamine release. Marginal behavioural changes such as these 
are compatible with histamine release but could also reflect a 
physiological response to stress. The severe bouts of coughing and
respiratory embarrassment seen in one animal given 0.1 mg CLP and a
type III hypersensitivity response animal was probably due to the
particulate nature of CLP blocking the air ways.
The animal treated with 0.01 mg ovalbumin which developed 
anaphylactic shock and the animals given 0.001 mg ovalbumin with 
histological anaphylaxis were relatively free of clinical symptoms 
at the previous challenge. Other members of the groups had shown a 
more marked but not constant picture of respiratory distress. This 
is consistent with the concept of a refractory or latent period 
before the animal is able to respond again,which in turn depends upon 
the number of mast cells activated and the amount of circulating anti­
body available. If there is competition for Fc receptors there may 
be a latent period before sufficient antigen specific antibody has 
been bound to elicit a measurable response upon contact with antigen.
The adsorption of specific antibody can be reversible producing a 
longer latent period. Guinea pigs treated with 0,001 mg ovalbumin 
probably had reaginic antibody present as histological anaphylaxis was 
observed, but in too small quantities to be detected by passive cutaneous
81
anaphylaxis. There was not likely to he any undetected reaginic 
antibody in animals treated with CLP to induce a type 1 hypersensitivity, 
as no histological signs of anaphylaxis were observed.
The anaphylactic and passive cutaneous anaphylaxis responses can 
be inhibited by the presence of other antibodies competing for the 
specific antigen. In guinea pig precipitating IgG2 antibodies can 
compete with reaginic IgGl antibody and using rabbit the presence of 
precipitating antibody has been shown to be inversely related to the 
severity of the anaphylactic response (Muckle, 1977). Neither groups 
of animals treated with CLP to induce a type I or type III hyper­
sensitivity response had detectable levels of precipitating antibody 
present to inhibit the development of anaphylaxis. Reaginic antibody 
was detected in animals treated to induce a type III hypersensitivity, 
although they received a greater quantity of CLP than those used in 
the type I hypersensitivity experiment, the development of reaginic 
antibody would appear to be attributable to the presence of 
agglutinating antibody prior to intratracheal treatment. This raises 
the question of whether the budded emphysema seen in these animals 
was a result of numerous small anaphylactic reactions over the 
challenge period. Maintenance of the reaginic antibody response at 
72 hours after heat treatment suggests that the antibody was of the 
IgG class.
The histological findings in the ovalbumin groups were consistent 
with an anaphylactic response, the non-budded emphysema indicating 
a recent lesion produced by an acute pathological process. The 
bright red colour of the areas on the surface of the lung showing 
the rupture of small capillaries had just occurred as a result of 
the final challenge with antigen. The lack of eosinophil infiltrations
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could be because these animals were killed immediately the 
respiratory symptoms had reached their peak and not two hours post 
mortem as Parish (I960) had done with the animals developing shock 
in his series of experiments.
The combined effect of saline and the non-sterile and parti­
culate nature of the CLP antigen contributed to the gross pathology 
found in the upper lobes of the lung. Despite the fact that CLP 
had been ground to reduce the size to 5 P» suspended in saline it 
produced agglomerates which could account for both the clinical 
observations and pathology observed, however, no yeast particles were 
observed in any of the lung sections.
The lesions found in animals treated to induce type III hyper­
sensitivity were characteristic of inhalation of a dust, showing 
areas with the alveolar cells sloughed off into the alveolar spaces 
and the presence of macrophages to remove cell debris and yeast.
The finding of the perivascular cuffing with mononuclear cells 
which extends into the alveolar space is a common observation and 
has been considered normal,particularly in the guinea pig. These 
collections of cells have been found with a high frequency in animals 
exposed to, or intratracheally injected with, certain dusts and may 
contain dust particles (Gross, 19?1). Gross thought that these 
cells were alveolar in origin not lymphocytic as a reticulin stain 
revealed the cells to be within the alveolar spaces. Acute 
inflammatory lesions in the vicinity of these cell collections 
result in their dispersal with partial loss of the reticulin framework. 
The significance of this type of lesion in relation to CLP exposure 
is unknown, except that their incidence increases in the presence of 
spontaneous chronic pulmonary disease. Animals treated with CLP to
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induce a type I hypersensitivity did not demonstrate any evidence for 
this lesion. The reason for the absence of a type III allergic 
alveolitis may have been due to the absence of precipitating 
antibody before the intratracheal treatments began, the initial 
four sensitizing doses may not have been sufficient to stimulate 
precipitin production.
The conclusions that can be drawn from this study are that CLP 
failed to induce a type I hypersensitivity response compared with 
ovalbumin which induced anaphylactic shock and reaginic antibody 
formation.
The intratracheal sensitization and challenge took some time 
to induce a response even using a potent allergen like ovalbumin.
If treatment had been prolonged the 0,001 mg ovalbumin group would have 
been expected to demonstrate reaginic activity. When examining a 
substance of low immunopotency such as CLP a longer exposure time 
could be required.
Intratracheal injection failed to induce precipitating antibody 
and type III hypersensitivity tissue damage against CLP but reaginic 
antibody was detected suggesting some immunological activity.
In comparison with ovalbumin, CLP does not pose an immunological 
hazard, however, as an inhaled dust CLP may pose a non-immunological 
problem as a physical irritant.
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CHAPTER 4
Assessment of the ability of Candida lipolytica protein
(CLP) to induce a hypersensitivity response in the 
gastrointestinal tract of sensitized guinea pigs and rats'
4.1 INTRODUCTION
There have been a number of studies evaluating C. lipolytica grown 
on n-alkanes (De Groot, 1970 and 1975; Shacklady, I969) and none have 
given any indication of immunological reactivity, although the immune 
system was not specifically examined.
In human feeding trials carried out by Scrimshaw (1979), C. utilis 
SCP produced skin lesions and C. lipolytica SCP induced nausea, 
vomiting and diarrhoea (NVD). These symptoms are similar to those 
associated with those of food allergy (Vaz _et , 1978) which resolve 
when the offending food is removed from the diet. Absorption of 
antigen in the sensitive individual can also result in hypersensitivity 
tissue damage either locally or systemically. A type I hypersensitivity 
reaction involving reaginic antibody may produce symptoms of NVD and 
appear on histological sections as cellular infiltrates of eosino­
phils and neutrophils in the gut (Shiner . et , 1975) or as skin 
reactions such as urticaria.
Type III hypersensitivity responses involving precipitating 
antibody can be produced by the formation of immune complexes 
especially with multivalent antigens, CLP may function as such an 
antigen. In antibody excess insoluble complexes that remain within 
the gastrointestinal tissue may be formed and through activation of
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the complement pathway these immune complexes can produce tissue 
damage. Soluble complexes found in antigen excess can enter the 
circulation and may become entrapped in the microvasculature of 
other organs such as the kidney and play an important role in the 
pathogenesis of glomerulonephrosis.
Of the hypersensitivity responses the most thoroughly 
investigated response is the reaction to milk proteins. This is 
most often seen in infants only a few months old and is characterised 
by diarrhoea, vomiting and a failure to thrive. It is thought to 
occur because the neonatal gut is not capable of excluding the larger 
antigenic molecules. Flat intestinal lesions associated with milk 
hypersensitivity have also been found in a sensitive infant in 
response to soya milk (Adment and Rubin, 1972). Soya based milk 
replacer for calves has also been seen to induce an immediate type 
hypersensitivity response producing symptoms of diarrhoea and 
demonstrable reaginic antibody (Barratt and Porter, 1979).
Development of this response was due to presence of soya antibodies 
before exposure to soya in the milk replacer which were believed to 
be of passive maternal origin. Transfer of antigen in human milk 
has been shown to take place by Jacobsson and Lindberg (1978) who 
detected bovine antigens and Hammings and Kalungara (1978)wheat 
antigens in human milk. If present in a mother's diet CLP may 
therefore be available to sensitize an infant by an indirect route, 
however, in animal multigeneration studies, G. lipolytica SCP did 
not appear to presensitize subsequent generations.
A proportion of the human population are termed atopic and 
have a predisposition to develop adverse immunological reactions to 
certain elements in their environment, therefore, avoidance of an
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antigen such as CLP, which may be incorporated into a wide range of 
processed foods, would prove extremely difficult. In addition 
modification of food during digestion can produce immunogenic factors 
which then complicate identification of the causative agent in food 
allergy (Atherton et al., 1978).
Absorption of antigen through the gastrointestinal tract may 
affect responses at other sites of exposure. It has been suggested 
by Berril (1975) that a correlation may exist between villous atrophy 
and lung disease, as seen in some cases of Bird Fanciers Lung, 
however, it is not clear whether these are concomitant or consecutive.
A similar type of situation could be envisaged in persons exposed to 
CLP by inhalation during its manufacture and who also consume the 
product.
It has been shown that CLP has antigenic properties if 
administered by subcutaneous injection (Chapter 2) and that 
absorption of antigen via the lung was sufficient to induce reaginic 
antibodies in animals possessing agglutinating antibody to mannan 
(Chapter 3).
The following study was carried out to determine if sufficient 
CLP antigen could be absorbed through the gut to induce hypersensitivity 
tissue damage. A variety of routes of sensitization and treatment 
were used, both high and low doses of CLP were employed to encompass 
a range of antigen exposure.
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4.2 MATERIALS
4.2.1 Animals
Female Sprague Dawley rats weighing 200-250 g were obtained 
from Olac 1976 Ltd., and fed Spratts laboratory animal diet No. 1 
in pellet form.
Dunkin Hartley guinea pigs were obtained and maintained as 
previously described in Section 2.2.1. Guinea pigs which had 
received CLP by intratracheal injection as described in Section 3.4.1 
were included in this experiment.
4.2.2 Candida lipolytica Protein Samples
Candida lipolytica grown on n-alkanes was supplied by the 
manufacturer in several forms. These were;
4.2.2.1 One per cent CLP guinea pig diet
This was formulated to contain 1 per cent protein (CLP 2.2.7.1).
4.2.2.2 Twenty per cent guinea pig diet
This was formulated to contain 20 per cent protein (CLP 2.2.7.1).
CLP dry powder as previously described in Section 2.2.7.1.
CLP enzyme digestions previously described in Section 2.2.7.3.
CLP mannan extracts as previously described in Section 2.2.7.4.
4.3 METHODS
4.3.1 Passive Cutaneous Anaphylaxis Technique
This was carried out as previously described in Section 3.3.2 except 
that rat sera were injected into recipient rats.
4.3.2 Double Immunodiffusion Technique
This was carried out as previously described in Section 2.3.2.
4.3.3 Passive Haemagglutination Technique
This was carried out as described in Section 2.3.3 but rat sera 
required absorption with SPEC to remove non-specific agglutinins 
to SRBG before testing,
4,4 EXPERIMENTAL
Twenty guinea pigs were sensitized with 1 mg CLP (2,2,7,1) by 
subcutaneous injection and ten with 400 mg CLP (2.2,7.1) by oral 
intubation (Table 4,1), Guinea pigs weighing 60O-7OO g (Section 3.4.1) 
which had been treated with a series of intratracheal injections from 
1.0-0.001 mg CLP (3.2.3.1) were also included in this experiment.
Seven days after completion of the sensitization procedures 
all animals including fifteen unsensitized guinea pigs were bled 
and serum samples collected. These were tested for agglutinating 
antibody against mannan TMPB III by passive haemagglutination and 
for precipitating antibodies by double immunodiffusion using CLP 
enzyme digests (2,2,7.3) s,nd mannan extracts (2,2,7.4).
Five rats were sensitized with 1 mg CLP by subcutaneous injection 
using the same regime as for guinea pigs (Table 4.2). These and 
ten unsensitized rats were similarly tested for presence of antibody.
Fourteen days after completion of the sensitization procedures, 
feeding and daily oral intubation of CLP commenced. Each group 
consisted of five animals.
Guinea pigs receiving 1 mg CLP were given either 0 (control)
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1 per cent or 20 per cent CLP in the diet, or I65 mg/lOO g body
weight CLP by oral intubation. Orally sensitized guinea pigs
received either 1 per cent CLP diet or 50 mg/lOO g body weight 
CLP by oral intubation. Guinea pigs treated by intratracheal injection 
received diet containing 20 per cent CLP, Unsensitized animals 
received either 0 (control), 1 per cent or 20 per cent CLP in the diet.
Sensitized rats were given I65 mg/lOO g body weight CLP by oral
intubation and unsensitized rats either 0 (control) or I65 mg/iOG g 
body weight CLP. The combinations of sensitization and treatments 
given are shown in Table 4.1 for guinea pig and Table 4,2 for rat. 
During the feeding programme all animals were observed for signs 
of loss of condition and diarrhoea.
After 2 weeks administration of CLP animals were killed at weekly 
intervals up to 5 weeks of treatment. Rats and guinea pigs given 
165 mg/loo g body weight CLP were killed after 4 weeks treatment. 
Animals were starved 12 hours prior to being killed by exsanguination 
under barbiturate anaesthesia (guinea pigs by cardiac puncture, rats 
from the aorta) and serum samples were collected.
At autopsy macroscopic observations were noted and the gastro­
intestinal tract was carefully examined for evidence of oedema, 
ulceration and haemorrhage. Samples of lung, liver, heart, kidney, 
thymus, mesenteric and cervical lymph nodes, spleen, adrenal, 
pituitary, stomach, duodenum, ileum at five points along its length, 
colon,caecum and rectum were taken and fixed in 10 per cent buffered 
formalin. Tissues were processed, 5 U sections cut, stained with 
Ehrlichs haematoxylin and eosin, then examined for evidence of hyper­
sensitivity tissue damage.
Sera were tested for the presence of reaginic antibody by
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passive cutaneous anaphylaxis using GLP (2.2.7,1) and for pre­
cipitating antibodies using GLP mannan extracts (2.2.7.^ ) and 
enzyme digests (2.2.7.3).
4.5 RESULTS
Haemagglutination titres obtained after the sensitization 
exposure to GLP by subcutaneous injection, oral intubation and 
intratracheal injection are shown on Table 4.1 for guinea pigs and 
Table 4.2 for rats. Unsensitized animals and those exposed to GLP 
by inhalation gave titres of less than 8 and only 60 per cent of 
orally treated animals produced titres of 8. All animals injected 
with GLP combined with EGA gave positive titres ranging from 8-64. 
None of the animals tested possessed precipitating antibody to 
either mannan extracts or enzyme digestions. During the treatment 
programme none of the animals exposed to GLP either orally or in 
the diet developed symptoms of diarrhoea or suffered a loss of 
condition.
Ingestion of GLP by unsensitized, orally and intratracheally 
treated guinea pigs failed to induce precipitating antibody. Six out 
of the twenty guinea pigs injected with GLP produced precipitin lines 
against GLP enzyme digests (Table 4.3)> two received 20 per cent GLP 
diet for two and three weeks, one received 1 per cent diet for 2 
weeks and three animals received I65 mg/lOO g body weight GLP orally 
for 4 weeks. Antibody activity was mainly directed against material 
produced by digestion with either the non-protease enzymes amylase, 
lipase and pancrease, or the protease enzyme chymotrypsin. Only two 
out of the twenty animals reacted with the DEAE sepharose mannan
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extracts, one received 20 per cent CLP diet for 5 weeks and the 
other 165 mg/100 g body weigt GLP by oral intubation for 4 weeks 
(Table 4,4), (this animal also reacted with the GLP enzyme digestions). 
The transient appearance of a precipitin response as seen in Section
2.5.2 was not observed in guinea pigs injected with 1 mg GLP and 
fed control diet.
Those animals receiving 20 per cent GLP diet developed reaginic 
antibody as determined by passive cutaneous anaphylaxis. Four had 
received 1 mg GLP by subcutaneous injection, and one 0.1 mg GLP by 
intratracheal injection (Table 4.5). Upon heating the sera for 4 hours 
at 56°G three of the responses were reduced or consisted of numerous 
discrete specks of colour indicating the presence of IgE antibody.
Sensitized and unsensitized rats given I65 mg/lOO g body weight 
GLP by oral intubation failed to produce precipitating or reaginic 
antibody despite the presence of agglutinating antibody before feeding.
At autopsy there was no evidence of oedema, ulceration or 
haemorrhage in the gastrointestinal tract of guinea pig or rat.
Several guinea pigs had pitted and scarred kidneys and the lungs of 
most guinea pigs were discoloured with small areas of collapse 
especially in the upper lobes of intratracheally treated animals.
Histological examination of the gastrointestinal tract did not 
reveal presence of ulceration, villous atrophy or flattening, or 
areas of infiltration of eosinophils, neutrophils and macrophages.
The observation of Peyers patches with active germinal centres was 
seen in both test and control animals.
The lymphoid tissues, spleen, thymus, cervical and mesenteric 
lymph nodes showed no abnormalities in architecture or cell 
distribution.
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Lungs from all guinea pigs examined showed varying degrees of 
bronchial and interstitial pneumonia. Eight animals had lesions 
consisting of well-demarked foci of mononuclear cells throughout 
the lung, this type of lesion is usually associated with viral 
infections. One animal receiving 20 per cent GLP in the diet and 
which possessed reaginic antibody showed this picture, however, 
other animals with this lesion were not producing reaginic antibody 
and vice versa, indicating that this lesion was not antibody 
mediated or related to ingestion of CLP,
Guinea pig kidneys showed signs of renal disease seen as focal 
areas of nephritis with areas of tubular hyperplasia in all but 
two of the animals. There was no evidence of glomerular damage in 
either rats or guinea pigs which might have been expected if soluble 
immune complexes had been formedo Rats showed only small amounts of 
tubular damage also not related to treatment,
4,6 DISCUSSION
The aim of this experiment was to presensitize animals before 
exposure to CLP in the diet in order to mimic the atopic condition.
Intratracheal injection and oral intubation routes by which CLP 
may normally be encountered did not readily induce agglutinating 
antibody. Intratracheal injection produced no response and only 
60 per cent of the orally "sensitized" animals gave titres of 8 which 
were well below titres obtained from subcutaneous injection of CLP 
in both rat and guinea pig. The absence of precipitating antibodies 
at one week after sensitization was expected as only a weak transient 
response had previously been observed at 2-6 weeks after sensitization 
(Section 2,5.2).
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Orally "sensitized" guinea pigs were either fed 1 per cent GLP 
diet or given 50 mg/lOO g body weight GLP by oral intubation to 
simulate a low level of exposure, but this did not stimulate a 
humoral response or elicit tissue damage.
Failure to initiate an immune response in these animals may have 
been due to insufficient available antigen, but unsensitized animals 
receiving 20 per cent GLP diet did not develop a humoral response 
either, suggesting that absorption of antigen was not taking place 
or a state of tolerance existed. Work by Hanson et aj, (1979) 
carried out in mice has shown that oral administration of antigen 
can produce tolerance to subsequent parenteral administrations, 
this may also hold true for oral administration of CLP,
Humoral responses of guinea pigs sensitized by injection were 
enhanced after feeding and oral administration of CLP. The number 
of animals responding and the type of response was related to the 
amount of antigen received. Only one animal receiving 1 per cent 
CLP diet produced a precipitin reaction against the CLP digests and 
three animals receiving I65 mg/lOO g body weight CLP produced a 
precipitin response against the CLP digests and mannan. All the 
animals receiving 20 per cent CLP diet developed an antibody response 
that included precipitating antibodies to either CLP digests and/or 
mannan, and/or a reaginic antibody. These results would indicate 
that antigenic material was absorbed through the gut to augment 
the initial immune response, however the concentration of antigenic 
material available was low, so that an artificially high dietary 
intake was required to elicit a response. Presence of increased 
absorption of dietary antigen in the sensitized guinea pig 
correlates with the findings of Paganelli et al, (1979) that in
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humans immune complex formation in response to dietary antigen is 
increased in atopic individuals. Rats similarly sensitized and 
given 165 mg/loo g body weight GLP did not, however, develop a 
precipitin response even although the agglutinin response after 
sensitization was good. This raises the question whether there are 
basic differences in gastrointestinal absorption between rats and 
guinea pigs and which species is the best model for man. It has 
been suggested that increased sensitivity of guinea pig gut compared 
to that of rat occurs because as a true herbivore the guinea pig 
has an inherent tolerance to cellulose which may be broken by 
exposure to an immunologically similar material such as carrageenan 
(Gangolli at ad,, 1979). The effects of breaking the tolerance to 
such a basic dietary component are severe and there was no histological 
evidence in the present study to suggest that CLP might have acted in 
this manner.
Only one animal exposed to CLP by intratracheal injection then 
fed 20 per cent CLP diet developed a reaginic response even although 
it did not possess agglutinating antibody before feeding. The 
relationship between inhalation and gastrointestinal exposure may be 
through links between the various secretory mucosae, McDermott and 
Binenstock (1979) have demonstrated selective localization of 
radiolabelled lymph node lymphocytes in the respiratory, genital and 
gastrointestinal mucosa, and that these cells were predominantly IgA 
bearing. Similarly, Meiss-Carrington et ad. (1979) detected IgA ■ 
antibody against dietary antigens, not only in gastrointestinal mucosa 
but in salivary gland and lactating mammary gland. Based on these 
observations the existence of a common mucosal or secretory immune system 
has been postulated. The traffic of sensitized lymphocytes to sites
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other than where initial contact with antigen took place may help 
to explain the acceleration of the humoral immune response after 
feeding, especially in animals previously sensitized by injection 
with GLP, as potentially a greater number of lymphocytes were 
exposed to the antigen. For CLP to reach these lymphocytes in the 
lamina propria absorption of antigen is required.
The difference between the humoral response obtained for rat 
and guinea pig may be due to differences in liver metabolism. Gut 
derived antigen passes directly to the liver where it can be removed 
from the circulation. Particulate antigens are phagocytesed by the 
Kupffer cells but homologous antibody is required for the removal of 
soluble antigens (Thomas ^  ad,, 1973). The presence of reaginic and 
precipitating antibodies in animals sensitized by injection and fed 
CLP suggests that the mechanisms exist by which tissue damage could 
occur. Such pathology as was observed in treated and control animals 
can, however, be commonly found in guinea pigs and rats and was not 
related to administration of CLP,
It is possible that as no tissue damage was detected the 
reaginic response had a protective role. This would be in keeping 
with the hypothesis of Jarrett (1977) that when IgE responses are 
stimulated, which occurs in animals receiving large doses of antigen 
and adjuvant, an antigen specific suppressor mechanism is also 
activated. It was further postulated that this suppressive mechanism 
is absent in atopic individuals which results in the increased levels 
of IgE to specific antigens. A mechanism such as this may have 
prevented tissue damage occurring in the guinea pig.
In the work described in this chapter, the animals were treated 
with CLP and sensitization was assessed by the presence of agglutinating
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antibody. The humoral response was enhanced and reaginic antibody 
demonstrated. The implications of this response are difficult to 
interpret because, although biologically active, the tissue damage 
that would be expected to be present was not found. Within the 
limits of this experiment CLP did not induce hypersensitivity tissue 
damage in the gastrointestinal tract of sensitized guinea pigs or 
rats.
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CHAPTER 5
General Discussion
Investigations into nutritional value and toxicity of CLP have 
shown it to be a potentially useful replacement for conventional 
sources of protein, however, observations made during the human 
feeding trials (Scrimshaw, 1979) posed the question as to whether 
CLP represented an antigenic hazard.
This series of experiments was undertaken to determine the 
immunogenic potential of CLP in terms of its ability to induce 
hypersensitivity type tissue damage. Experiments were performed with 
a view to establishing suitable model systems to investigate this 
aspect of toxicity in some detail.
The first experimental chapter dealt with the ability of CLP 
to stimulate the immune response. Humoral and cell mediated immunity 
were examined after administration of separated fractions of the 
yeast (whole cells, cell contents and cell walls) so that the major 
antigenic component of the yeast could be identified, however, the 
success of such a distinction depends upon the purity of the separation. 
Antigens suitable for use in immunological assay systems had been 
prepared from CLP, these were the cell wall mannan extracts and 
various enzyme digestions.
The important antigenic materials of CLP were found to be located 
within the cell wall portion of the yeast, as the development of the 
precipitin response was almost entirely confined to animals treated 
with the cell wall preparations in all three species examined 
(Section 2.5.1). Use of wet yeast preparations may reflect the
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antigenicity of the live yeast rather than that of the spray dried 
product. Indeed, use of dry product for sensitization (CLP 2.2.7.1) 
although inducing good agglutinin responses only produced a weak 
transient precipitin response. This may be due to the partial 
destruction of antigenic material during processing, or that as 
complete CLP was administered the amount of antigenic material 
received was below that required to stimulate a precipitin response.
Severe treatment of CLP after the initial enzyme digestions 
using the french press and sodium dodecyl sulphate had succeeded in 
exposing additional antigenic domains. These preparations were 
sensitive in detecting the humoral response in guinea pigs and mice.
The variety of individual responses obtained may reflect the diversity 
of antigen sites available as well as the individual nature of the 
immune response.
During milder sequential digestion of CLP a limited number of 
sites were revealed. Exposure of the antigenic areas took place 
after digestion with intestinal enzymes, which was demonstrated using 
sera known to react with the range of prepared antigens (Section 2.5.5) 
A concentration step was required with this technique before 
sufficient antigen was present to give a precipitin response. This 
finding agrees with the igi vitro work of Hibino at ad. (1974) 
that the breakdown of CLP occurs in the lower gut. At this point 
the gut flora population is at its most stable and bacterial activity 
may serve to affect the amount of antigen exposed. Types of bacteria 
present in the gut alter with strain as well as species of laboratory 
animal chosen (Vielleux, 1981), thus metabolism of CLP may change 
between animal models.
The antigens, mannan TMPB III and the product of CLP after
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incubation with gastric and intestinal juices are heat labile as 
seen by their failure to produce agglutination and precipitation 
lines after heating at 65°G for 6 hours, thus providing a suitable 
method for antigen removal. Mannans extracted from G. albicans 
(Pepys, 1969) are not all heat labile; precipitin arcs obtained 
from heat stable mannans were described as "fuzzy" and those of the 
heat labile mannans "well-defined", as found in these studies 
(Fig, 2,3). The extraction process employed to obtain GLP mannan 
may have been confined to the heat labile mannans only, however 
the precipitin response to heat treated mannan was not examined,
Mannans from untreated GLP which had passed through a DEAE 
sepharose column exhibited antigenic properties. Those from alkali 
treated CLP which originally produced nausea, vomitting and diarrhoea 
(NVD) in man were negative. These findings indicate that perhaps the 
charge on the mannan molecules was altered so as to express the 
antigenic configuration and that the antigenic polysaccharides were 
possibly removed during alkali treatment. The latter would support 
the theory that evolution of H^S was responsible for the NVD syndrome 
rather than an immunological factor. Materials likely to be leached 
out of the cell wall during alkali treatment such as glucan, poly­
glucose and mannan, are known to be immunologically active having 
immunosuppressive (Ellner and Daniel, 1979) and adjuvant properties 
(Cook at ad,, I98O).
An assay system based on sequential digestion and testing for 
antigen release would provide a method of monitoring antigen content 
of this and similar products in any future study. Had samples of 
CLP been available after alkali and subsequent acid treatment 
it would have been possible to establish if the antigenic material
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detected in these experiments was reduced or removed during the 
processing steps already proposed.
Candida lipolytica, the yeast from which CLP is derived shares 
antigenic configurations with Candida pathogens., The structures 
of CLP mannans have not been identified but approximately 38 per cent 
of the human sera examined possessed an agglutinating antibody to 
CLP mannan (Section 2,5.3)1 thereby representing a potentially 
sensitive population.
Development of either the agglutinating or precipitating 
antibody response was dependent on the amount of cell wall material 
administered. This parallels the observation made by Stallybrass 
(1964) that agglutinating antibody is present in superficial 
Candida infections (low antigen concentrations) and precipitating 
antibody in systemic infections (high antigen concentrations),
The distinction between the two types of antibody may be 
related to their concentration in the sera, however, the profile of 
the humoral response to CLP in the guinea pig (Section 2.5.2) 
revealed no direct relationship between the titre of agglutinating 
antibody and presence of precipitating antibodies. If a good 
precipitin response had also been obtained the identify of the 
immunoglobulin classes involved in the development of the humoral 
response to CLP could have been characterised.
Cell mediated immunity was stimulated using CLP wet yeast 
preparations as shown by increased levels of lymphocyte proliferation 
in response to homologous antigen challenge. It was, however, 
difficult to distinguish differences between the activity of each 
yeast fraction. Omission of PCA from the sensitization regime may 
have allowed differences in activity to be observed, whereby levels
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of proliferation obtained with the potentially less immunogenic 
fractions may have been substantially reduced. Other studies of 
lymphocyte proliferation in individuals presenting cutaneous 
lesions after ingesting G, utilis SGP demonstrated lymphocyte 
activation (Schrimshaw, 1979)» however, there has been no similar 
report of lymphocyte activation in the individuals which developed 
the NVD syndrome after ingestion of GLP,
The consequences of CLP inhalation were examined (Chapter 3) 
with regard to development of type I and type III hypersensitivity 
responses (Sections 3*4.1 and 3*4,2).
In the system chosen for this investigation, based upon the 
work of Parish et (I960), the positive control material ovalbumin 
for type I hypersensitivity produced a classical picture of anaphylaxis. 
This was characterised by the presence of pale inflated lungs at 
autopsy, histology of emphysema with red blood cells in the alveolar 
spaces and reaginic antibody, CLP failed to produce a type I response, 
however, as it is less immunogenic than ovalbumin, a longer period of 
exposure may be necessary. The lack of correlation between production 
of clinical and histological anaphylaxis and the levels of reaginic 
antibody detected generally occurs because serum antibody levels do 
not account for that antibody which is bound to mast cells in the 
tissues,
CLP failed to induce a type III hypersensitivity response in 
guinea pigs that had been pretreated with CLP whole cells in order 
to induce an agglutinating antibody to mannan prior to intratracheal 
treatment,
Salvaggio (1979) reviewed the characteristics of an allergic 
alveolitis or hypersensitivity pneumonitis which were, that they
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are uniformly associated with precipitating antibody against the 
offending antigen, that the lesions are composed of mononuclear 
interstitial and alveolar infiltrates, that granuloma formation is 
a prominent feature of the lesions and alveolar cells characteristic 
of activated macrophages are found within the piiLmonary lesions.
In the present study alveolar thickening, areas of consolidation and 
desquamation of alveolar cells into the alveolar spaces (some of which 
resembled macrophages) were found in these animals. Induction of 
some pathological changes, however, could be a result of trauma 
associated with the instillation of antigen in a saline vehicle. The 
absence of precipitating antibodies confirm that these findings were 
not related to a type III hypersensitivity response.
Inhalation of GLP in the presence of an agglutinating antibody 
did, on the other hand, induce a reaginic antibody. As 38 per cent 
of the human population (Section 2,5.3) have agglutinating antibody 
to GLP mannan it is conceivable that a type I hypersensitivity response 
could be induced in man. If the guinea pigs had been sensitized using 
sufficient cell wall material to induce precipitating antibody, it is 
doubtful whether the type I response would have evolved as the 
pathological role of precipitating antibodies is complex and they may 
mediate type III responses and in addition they can act as blocking 
antibodies. In a clinical study Devey et ad, (1975)» when examining 
castor bean dust inhalation, found high levels of castor bean 
specific IgC4 antibodies in the serum of two subjects who did not 
show symptoms of castor bean inhalation consistent with their 
exposure. They suggested that these antibodies could have a blocking 
function. The clinical significance of precipitating antibody to 
G, albicans found in cases of candidiasis is uncertain, especially
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with respect to the inhalation or ingestion of a Candida based 
SGP.
The effect of GLP ingestion on the gastrointestinal tract was 
examined in guinea pigs which had been exposed to GLP by oral 
intubation or subcutaneous injection prior to feeding (Section 4,5). 
Animals orally exposed to GLP developed a low grade agglutinin 
response and further development of the antibody response did not 
occur upon subsequent GLP ingestion. This might be expected as new 
food materials which will be regularly encountered in the diet need 
to be recognised and accepted by the immune system, GLP protein 
antigen was absorbed across the gut, but, unrealistically high 
concentrations of GLP in the diet were required to enhance the 
humoral response of guinea pigs sensitized by injection. In this 
system it is unclear whether the presence of GLP specific serum 
antibody affected absorption, but sufficient antigen was absorbed 
to stimulate cells primed by injection.
Examination of GLP ingestion in guinea pigs previously exposed 
to GLP by intratracheal injection failed to confirm any relation­
ship between inhalation of antigen and initiation of gastrointestinal 
lesions as put forward by Berril (1975) for bird-fanciers lung. 
Sensitivity to GLP after intratracheal administration, however, had 
not been demonstrated prior to feeding and as only one guinea pig 
developed a reaginic antibody after being fed 20 per cent GLP diet 
it was difficult to relate cause and effect. A local immune response 
may have developed in the lung associated lymphoid tissues in this 
animal which intensified upon ingestion of GLP, alternatively
gastrointestinal permeability may have been altered allowing increased 
antigen absorption in this animal, however, no tissue damage was
109
observed.
Production of precipitating antibody in response to ingestion 
of GLP after sensitization by injection was confined to the guinea 
pig. Similar treatment of rats produced a good agglutinin response 
but no subsequent development of the antibody response. This could 
be ascribed to differences in absorption of macromolecules across 
the gut between the two species. Although the rats did not respond 
when given I65 mg/lOO g body weight GLP, a level which induced 
precipitating antibody in guinea pig, they may have responded if 
exposed to the maximum concentration of 20 per cent GLP diet.
In the studies described, GLP under optimum conditions displayed 
weak antigenic properties demonstrated by the development of both 
humoral and cell mediated immunity. The major source of GLP 
antigenic material resided within the yeast cell wall, the activity 
of which was reduced during the spray drying process and could be 
removed by heat treatment, indicating heat labile antigens.
Mannan extracted from the low RNA GLP did not express antigenic 
activity, but mannan extracted from untreated GLP and fractionated 
using a DEAE sepharose column shared antigenic configurations with 
other members of the Gandida genus.
Inhalation of GLP compared to ovalbumin failed to induce a type 
I hypersensitivity response in the lung, but succeeded in doing so in 
the presence of agglutinating antibody to mannan. Although there 
was some evidence of tissue damage after intratracheal administration 
of GLP, this was consistent with the inhalation of a particulate 
material and not with a type III hypersensitivity response. This 
fact is substantiated by the absence of precipitating antibody.
Ingestion of GLP induced a low grade agglutinating antibody.
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Animals presensitized by subcutaneous injection and fed CLP produced 
an enhanced response, however this required unrealistically large 
doses of GLP in normal dietary terms, and no tissue damage was 
observed as a consequence of this.
Although it has been established that GLP is a low grade 
immunogen, further experimentation could serve to elucidate its 
potential as an antigen.
Inhaled GLP may either be removed on the mucocilliary blanlcet 
or undergo phagocytosis by macrophages. Similarly antigenic material 
absorbed through the gut and transported to the liver via the 
portal system may also undergo phagocytosis. GLP has been shown to 
be non-toxic to macrophages (Shacklady, 19?6). It has been 
demonstrated that macrophages including Kupffer cells have the 
properties of either phagocytosis or antigen presentation. These 
two cell populations can be distinguished because the latter have 
the la antigens on their surface (Rogoff and Lipsky, I98O). The 
number of la bearing macrophages have been shown to increase with 
antigen stimulation (Seller et al., I98O), Examination of the 
surface markers on macrophages from GLP treated animals may give 
information as to whether it is presented as an antigen by the 
macrophages, it may also provide a method for assessing antigenic 
potential of other new materials.
Feeding of GLP to sensitized guinea pigs induced reaginic 
and precipitating antibodies, the site of biological action of which 
was unknown. Ghallenge of these animals by intratracheal route and 
examination of the gut using histamine release in response to antigen 
might shed light upon the site of action of the reaginic antibody.
Examination of the orally treated animals showed that ingested
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CLP was recognised as antigenic material indicating that a state of 
tolerance existed. To test this hypothesis, lymphocytes taken from 
an orally treated animal when transferred to a normal recipient 
should prevent the development of an immune response initiated 
by injected antigen (Miller and Hanson, 1979). Oral exposure to 
CLP may well depress the agglutinin response obtained after 
subcutaneous injection with GLP.
Paganelli (1979) suggested that absorption of food antigens was 
increased in the atopic person. The enhancement of the immune 
response in sensitized animals may reflect increased permeability 
in the gut. This could be examined by monitoring changes in 
absorption of an inert material across the gut in treated animals.
The choice of an animal model to examine any SGP should take into 
account the pathogenicity of the organism used. The guinea pig was 
an ideal model for ovalbumin induced anaphylaxis but to assess the 
implication of inhalation of GLP in individuals with an agglutinating 
antibody to mannan, the rabbit may prove a more realistic model. The 
effect of GLP inhalation should be examined in rabbits with and 
without the naturally arising agglutinating antibody to mannan, 
preferably using a dust inhalation chamber, thus eliminating the 
pathology due to the intratracheal injection of saline.
Guinea pigs were selected for the gastrointestinal model because 
of their sensitivity to ingested polysaccharides, however, this may 
be a finding related to the herbivore habit, for Grasso ^t al.(1973) 
point out that rabbits and guinea pigs developed gastrointestinal 
lesions to carrageenan but ferret, mouse and man, all of which are 
omnivores, did not respond. Use of another species might provide a 
better experimental model for this type of study.
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Single cell protein organisms whether they be yeast, algal or 
fungal represent species that can be grown under controlled 
conditions to produce materials needed by man, this has been said 
to herald a new period in agriculture. Allergies and intolerances 
to the conventional sources of protein such as cereals, fish, egg, 
milk, pulses, meat and cheese have been recognised. Compared with 
some of these materials, it was difficult to induce a response 
using GLP final product.
Introduction of any SGP for human consumption has not been 
successful and apart from problems related to product safety there 
are psychological barriers to overcome. The future of SGP for 
human consumption is uncertain, but if technological development 
follows in the footsteps of the creative imaginations of science 
fiction writers, SGP may become accepted. Azimov (1972) in "The 
Gods Themselves" describes a moon colony in the year 2100 whose 
food resources are based on algal and fungal materials, which is 
akin to the original concept for development of a SGP for manned 
space flight.
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